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Activation of ventral tegmental area (VTA) dopaminergic (DA) neurons by 
ethanol has been implicated in the rewarding and reinforcing actions of ethanol.  
GABAergic transmission is thought to play an important role in regulating the 
activity of DA neurons.  While at most central synapses ethanol generally 
increases inhibitory synaptic transmission, no studies have explored the effect of 
acute ethanol on GABAergic transmission in the VTA.  Here we investigated how 
ethanol modulates GABAergic transmission in the VTA in relation to the overall 
action of ethanol on VTA-DA neuron activity.  We demonstrated that ethanol 
dose-dependently enhances action potential-dependent and -independent GABA 
release onto VTA-DA neurons.  Utilizing whole-cell voltage clamp recording 
techniques, ethanol increased both spontaneous and miniature inhibitory 
postsynaptic current (s/mIPSC) frequency while having minimal effect on 
s/mIPSC amplitude.  The ethanol enhancement in GABA release was 
independent of GABAB auto-receptor inhibition of release.  Intra-terminal calcium 
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levels regulate neurotransmitter release, thus we investigated how modulation of 
calcium levels would affect the ethanol-enhancement in GABA release.  Ethanol 
enhanced mIPSC frequency in the presence of the voltage-gated calcium 
channel blockers, cadmium chloride and nicardipine.  However, blockade of 
intracellular calcium stores with 2-APB and cyclopiazonic acid eliminated the 
ethanol-enhancement of mIPSC frequency.  Intracellular calcium stores are 
regulated via Gq protein-coupled receptors such as the 5-HT2C receptor.  5-HT2C 
receptor activation robustly enhanced mIPSC frequency whereas blockade 
inhibited the ethanol-enhancement in mIPSC frequency.  These observations 
suggest that increased calcium release from intracellular stores via 5-HT2C 
receptor activation is involved in the ethanol-enhancement of GABA release onto 
VTA-DA neurons.  Utilizing cell-attached current-clamp recordings, we 
demonstrated that the ethanol-enhancement of VTA-DA neuron activity is 
modulated by the concurrent enhancement in GABA release.  Blockade and 
activation of GABAA receptors enhanced and reversed, respectively, the 
stimulatory effect of ethanol on VTA-DA neurons.   Mu-opioid receptors (MORs) 
on GABAergic interneurons have been demonstrated to modulate both basal and 
ethanol-enhanced VTA-DA activity in vivo, though we failed to demonstrate such 
an effect in vitro.  Overall, the results of this study suggest that the 5-HT2C 
receptor and intra-terminal calcium-dependent ethanol enhancement in GABA 
release acts to regulate the overall stimulatory effect of ethanol on VTA-DA 
activity.            
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Chapter 1: Introduction 
1-1. Alcohol dependence 
1-1-1. Definition 
 „Addiction‟ as a disease concept is recognized by the biomedical 
community and is defined by a specific set of criteria.  According to the 
Diagnostic and Statistical Manual of Mental Disorders, the American Psychiatric 
Association (DSM-IV; APA 1994) for clinicians uses the term „substance 
dependence‟ instead of „addiction‟ in referring to a set of seven symptoms 
indicative of a persistent and uncontrolled use of a substance despite serious 
negative consequences.  The criteria for differentiating substance dependence 
versus substance abuse involves the presence of three or more of the listed 
seven cardinal symptoms manifesting themselves in any one twelve-month 
period.  These symptoms include (1) tolerance, (2) withdrawal, (3) prolonged or 
excessive use, (4) persistent desire to continue use, (5) excessive time allotted to 
drug seeking and use, (6) negative impacts on social, occupational and 
recreational activities resulting from use and (7) continued drug use despite the 
user‟s knowledge of negative drug-induced problems.  These criteria used to 
diagnose substance dependence apply to all drug types regardless of 
pharmacological action.  However, the National Institute on Alcohol Abuse and 
Alcoholism (NIAAA) defines „alcoholism‟ or „alcohol dependence‟ to the lay 
person as a disease that includes the following four symptoms: craving, loss of 
control, physical dependence, and tolerance.  However, dependence does not 
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come about solely due to excessive use.  In fact, it is well established that drug 
dependence consists of two major components:  (1) a genetic predisposition 
whereby 40-60% of the vulnerability to dependence can be attributed to genetic 
factors (Goldman et al., 2005; Hiroi and Agatsuma, 2005) and (2) the abuse 
component whereby excessive drug use results in synaptic and non-synaptic 
dysfunctions that over a long period of time result in compensatory changes that 
manifests itself into the addictive state.   
1-1-2. Economic and societal impact 
 According to a polled study conducted during 1990-1992, 91.5% of 
American adults reported experience with alcohol, with 14% of those being 
dependent (Anthony et al., 1994).  These data support the notion that alcohol 
abuse and dependence is particularly pervasive in this country.  According to the 
NIAAA, alcohol abuse has a substantial economic cost on the United States, with 
an estimated societal cost of $185 billion in 1998.  This estimate includes the 
costs associated with health care expenditures, productivity impacts, motor 
vehicle crashes, crime, social welfare administration and other factors.  In 2004, 
40% of all traffic crash fatalities were alcohol related (Alcohol Epidemiologic Data 
System, NIAAA, 2006).  Obviously, alcohol abuse and dependence have major 
impacts on our society and therefore the necessary resources should be made 





1-1-3. Current treatment  
 There is no cure for alcoholism; however, there are several available 
medications that have displayed limited effectiveness in some people in 
promoting abstinence from alcohol consumption.  These drugs include: 
naltrexone, disulfiram, acamprosate and topiramate (Brunton et al., 2006).  In 
1994, the Food and Drug Administration approved the use of naltrexone, a non-
selective opioid receptor antagonist, for therapeutic use in alcohol dependence 
(Franklin, 1995).  The therapeutic utility of naltrexone is believed to be mediated 
through a dampening of the excitatory effects of alcohol on the mesolimbic 
system.  However, the precise mechanism of naltrexone in mediating this effect 
is still unclear.  Dilsufiram is used as a deterrent to alcohol consumption.  When 
given alone disulfiram is relatively innocuous.  However, due to its action as an 
inhibitor of aldehyde dehydrogenase, adjunctive alcohol consumption results in a 
buildup of acetaldehyde thus causing the patient to become very ill.  Other drugs 
which show some effectiveness in treatment, although the mechanisms are even 
less clear, include the gamma-aminobutyric acid (GABA) analogue, 
acamprosate, and topiramate, which is also used to treat seizure disorders 
(Brunton et al., 2006). 
1-2. Ventral Tegmental Area 
1-2-1. Anatomy and connectivity 
A primary system involved in drug dependence is the mesocorticolimbic 
dopamine pathway, originating in the ventral tegmental area (VTA).  The VTA 
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was first described in the opossum brain, although it was originally referred to as 
the ventral tegmental nucleus before adopting its more common nomenclature 
(Tsai, 1925).  The VTA is also synonymous with the A10 nucleus, a term used to 
classify areas containing dopaminergic (DA) cell bodies along with two other DA 
nuclei in the ventral midbrain, the A8 and A9, referring to the retrorubral field 
(RRF) and substantia nigra pars compacta (SNc), respectively (Ungerstedt, 
1971).  In a horizontal section, the VTA is situated posterior to the lateral 
hypothalamic area (LHA), medial to the SNc and medial terminal nucleus of the 
accessory optic tract (MT) and anterior to the oculomotor nerve (3n) and medial 
lemniscus (ml).  Although not necessarily consistent across species, the VTA can 
further be subdivided into four distinct regions: paranigral nucleus (PN), 
parabrachial pigmented area (PBP), parafasciculus retroflexus area (PFR) and 
the ventral tegmental tail (VTT) (Ikemoto, 2007).  The PN and PBP, located 
respectively in the posterior ventromedial and anterior ventrolateral areas of the 
VTA contain a high density of DA cell bodies, whereas the PFR and VTT contain 
a low density of DA cell bodies. 
The VTA consists primarily of DA and non-DA cell bodies which project to 
and receive inputs from a variety of mesocorticolimbic structures.    DA cell 
bodies from the posteromedial regions of the VTA, including the PN, project to 
the ventromedial striatum, consisting of the medial nucleus accumbens (NAc) 
shell and the medial olfactory tubercle, whereas DA cell bodies in the lateral 
VTA, including the PBP, send projections to the lateral tubercle, lateral NAc shell, 
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NAc core and basolateral amygdala (BLA) (Ikemoto, 2007).  VTA-DA cell bodies 
also send projections to the medial prefrontal cortex (mPFC) (Berger et al., 
1976), lateral septum (Lindvall, 1975), amygdala (Ungerstedt, 1971; Albanese 
and Minciacchi, 1983) and hippocampus (Swanson, 1982).  VTA-DA neurons 
projecting to the mPFC and BLA originate primarily from the PN and the 
ventromedial PBP (Ford et al., 2006; Lammel et al., 2008).  
The VTA also receives reciprocal excitatory and inhibitory innervations 
from multiple brain regions.  Glutamatergic inputs to the VTA arise from the 
mPFC, subthalamic nucleus, and the pedunculopontine nucleus (Christie et al., 
1985; Groenewegen and Berendse, 1990; Sesack and Pickel, 1992; Charara et 
al., 1996).  Glutamatergic inputs from the mPFC synapse onto both DA and 
GABAergic neurons in the VTA (Carr and Sesack, 2000b).  A recent study 
utilizing retrograde tracer labeling demonstrated that nearly all brain structures 
projecting to the VTA send glutamatergic afferents (Geisler et al., 2007), thus 
supporting the idea that the VTA integrates excitatory information from a variety 
of areas.  GABAergic neurons from the NAc and ventral pallidum project to VTA 
(Walaas and Fonnum, 1980), and VTA-GABAergic neurons project to both the 
mPFC (Carr and Sesack, 2000a) and the NAc (Van Bockstaele and Pickel, 
1995).  Additionally, local VTA GABAergic neurons (interneurons) project onto 
neighboring VTA-DA cells and are thought regulate the activity of these DA cells 
via tonic inhibition (Johnson and North, 1992a).  Additional brain regions which 
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innervate the VTA include serotonergic afferents from the midbrain raphe nuclei 
that innervate both DA and GABAergic neurons (Herve et al., 1987).       
1-2-2. Cell types and electrophysiological properties 
 Neurons in the VTA are classified as primary, secondary and tertiary 
(Grace and Onn, 1989; Johnson and North, 1992b; Cameron et al., 1997; 
Neuhoff et al., 2002).  Primary neurons are considered dopaminergic and can be 
identified by the presence of tyrosine hydroxylase (TH), the rate-limiting enzyme 
involved in the biosynthesis of dopamine.  Primary and tertiary neurons both 
exhibit a slowly activating inward current in response to a hyperpolarizing step 
that is mediated via cyclic nucleotide-regulated cation channels (HCN, Ih).  
Additionally, both cell types display pacemaker firing (1-5 Hz) in vitro and long-
duration action potentials.  Secondary cells contain GABA and do not possess an 
Ih.  They have shorter action potentials and exhibit rapid firing (>8 Hz), although 
one group has identified a subset of TH(-) VTA cells that exhibit very slow firing 
(<1 Hz) (Korotkova et al., 2003).   
Primary and tertiary neurons are differentiated by their responses to mu-
opioid receptor (MOR) activation.  MOR agonists inhibit tertiary neurons and less 
than one-third of these cells are TH(+) (Cameron et al., 1997).  Alternatively, 
MORs agonists either have no effect or disinhibit primary cells via inhibition of 
local GABAergic interneurons (Johnson and North, 1992a; Margolis et al., 2003).  
It should be noted however, that disinhibition of principal cells is not reliably 
demonstrated in vitro, possibly due to the loss of VTA circuitry during slice 
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preparation.  Margolis et al. (2003) observed a disinhibitory effect by the MOR 
agonist, DAMGO, in less than half of the principle cells studied.  Additionally, in 
the Johnson and North (1992a) study, a high extracellular K+ concentration was 
required to potentiate GABA tone in order to see a disinhibitory effect of MOR 
activation.  kappa-opioid receptor (KOR) activation inhibits a subset of principal 
and tertiary cells but not secondary cells (Margolis et al., 2003).  Secondary cells 
are also inhibited by MOR agonists (Lacey et al., 1989; Johnson and North, 
1992a).   
 Based on the aforementioned studies, it appears that the original 
classification of two distinct neuron subtypes in the VTA, DA and GABAergic, is a 
gross oversimplification of the neuronal population in this brain region.  Indeed, 
some VTA cells express both TH and glutamic acid decarboxylase (GAD), a 
marker for GABAergic cells.  One study showed that 27% of VTA cells express 
both (Klink et al., 2001) and in another study about 13% of VTA cells examined 
expressed both markers (Korotkova et al., 2003).  Additionally, one study 
suggests that glutamatergic neurons are also present within the VTA (Yamaguchi 
et al., 2007).  One study in particular claims that there is no reliable physiological 
marker selective for DA neurons in the VTA, including: cell morphology, Ih size, 
spontaneous firing rate, input resistance, dopamine D2 receptor agonist inhibition 
and action potential duration (Margolis et al., 2006).  However, the authors do 
concede that Ih(-) neurons are reliably non-DA, so using this criteria for 
distinguishing between DA and non-DA neurons does have some merit.  
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Additionally, even immunohistochemical classification of DA neurons is not 
without its problems.  In mice, as the duration of the whole-cell recording 
increases, the effectiveness of post-hoc classification of recorded neurons 
diminishes (Zhang et al., 2008).  Furthermore, the authors contend that Ih is 
indeed sufficient to differentiate between DA and non-DA cells in the VTA.  
1-2-3. Neural substrates of addiction 
1-2-3-1. Mesocorticolimbic system 
DA neurons of the VTA constitute the central locus of the 
mesocorticolimbic dopamine system and send projections to the NAc, PFC, BLA 
and a variety of other corticolimbic structures (Albanese and Minciacchi, 1983; 
Oades and Halliday, 1987).  Most drugs of abuse pharmacologically activate 
VTA-DA neurons via a variety of mechanisms culminating in aberrant release of 
DA onto these targets.  Such pathological activation of the mesolimbic pathway is 
considered a primary step in the development and expression of drug 
dependence and addiction.   
1-2-3-2. Dopamine and reward/reinforcement 
 An issue that has been hotly debated during the past few decades is the 
precise role of dopamine in both reward and reinforcement (Wise, 2004).  Since 
dopamine levels rise during consumption of reward, dopamine is perceived as 
the „pleasure signal‟ which mediates the hedonic qualities of both natural rewards 
(food, drink, sex) and drugs of abuse.  This theory is termed the „anhedonia 
hypothesis‟ because pharmacological blockade of the mesolimbic dopamine 
9 
 
system blocks the hedonic properties of food rewards (Wise et al., 1978).  
Therefore, dopamine was initially believed to be required for a stimulus to be 
perceived as „good‟.   However, this is not necessarily true.  Several studies 
support the idea that a hedonic state can be achieved even in the absence of 
dopamine (Berridge et al., 1989; Treit and Berridge, 1990; Berridge and 
Robinson, 1998; Cannon and Palmiter, 2003; Robinson et al., 2005).  Developed 
from these studies was the „incentive salience‟ hypothesis which states that 
dopamine is not required for „liking‟ a reward, but is required for „wanting‟ a 
reward (Berridge and Robinson, 1998).  This hypothesis claims that dopamine is 
required for converting an otherwise neutral stimulus associated with a reward 
into an attractive or desirable quality that motivates the animal to obtain the 
reward.  This theory transforms the role of dopamine from the early view of a 
passive consequence of reward consumption to a more active role in regulating 
the learning associated with motivational aspects pertained to seeking and 
obtaining a reward.  
Evidence also suggests a role for dopamine in „reinforcement‟, which is a 
term used to describe the creation of a strong association between a rewarding 
stimulus and the behavior that led to obtaining that rewarding stimulus.  Support 
for the role of dopamine in reinforcement comes from numerous in vivo studies.  
Animals will normally learn to lever-press to obtain a reward, but not under 
conditions of dopamine blockade (Wise and Schwartz, 1981).   Additionally, 
under dopamine blockade, animals fail to exhibit preference for environments 
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(conditioned place preference) associated with the receipt of a reward (Spyraki et 
al., 1982; Spyraki et al., 1983).  These studies suggest that dopamine is required 
in order to learn that a particular behavior will result in a reward. 
 In a landmark series of behavioral studies with primates, phasic activation 
of dopamine neurons was shown to function as a reward predictor (Schultz et al., 
1993; Mirenowicz and Schultz, 1994; Schultz et al., 1997).  In these studies, 
when a reward (sip of fruit juice) was administered in the absence of a preceding 
conditioned stimulus, dopamine neurons produced a phasic increase in activity 
upon administration of a reward.  However, after learning, the increase in 
dopamine neuron activity occurred at the presentation of the conditioned stimulus 
and no phasic response occurred during administration of the reward.  
Conversely, when the expected reward was withheld, there was a phasic 
decrease below the tonic activity of dopamine neurons at the time the reward 
should have been delivered.  Thus, changes in dopamine neuron firing patterns 
are positively correlated with an unexpected or better than expected reward, and 
negatively correlated with a reward that is less than expected.  Therefore, DA 
neuron activity may be important for processing predictive cues and/or 
influencing reward-maximizing behaviors, rather than a direct representation of a 
hedonic state as a consequence of the rewarding stimuli. 
1-2-4. Ethanol and the mesolimbic system 
1-2-4-1. Ethanol enhances dopamine release 
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 It is well established that dopamine transmission within the 
mesocorticolimbic system is a critical component in the regulation of alcohol 
drinking behaviors.  Systemic administration of dopamine agonists and 
antagonists reduced alcohol drinking in rats (Pfeffer and Samson, 1986; Pfeffer 
and Samson, 1988).  Local microinjection of dopamine antagonists and agonists 
into the NAc terminated and prolonged ethanol drinking, respectively (Samson et 
al., 1992).  Additionally, D1 and D2 receptor antagonism reduced ethanol seeking 
behavior in rats (Czachowski et al., 2001; Liu and Weiss, 2002), and genetic 
deletion of these receptors in mice attenuates alcohol-seeking and consumption 
(El-Ghundi et al., 1998; Phillips et al., 1998).  In vivo microdialysis studies have 
demonstrated an increase in dopamine levels in the NAc in P and Wistar rats 
prior to and during ethanol self-administration (Weiss et al., 1993; Weiss et al., 
1996; Gonzales and Weiss, 1998; Melendez et al., 2002).   
Several recent studies have demonstrated that the ethanol-induced 
increase in dopamine release to the NAc is subregion dependent.  Intravenous 
ethanol administration produced a greater increase in dopamine levels in the 
NAc shell as compared to the core, with the core only seeing a significant 
increase in dopamine at the highest ethanol concentration tested (Howard et al., 
2008).  Neither the shell nor core exhibited a significant increase in dopamine 
release during operant ethanol consumption, however, the core-shell border did 
exhibit an increase in dopamine release under this paradigm (Howard et al., 
2009).  Since VTA subregions project topographically to the NAc, these studies 
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suggest that the projections from the medial VTA may be more important in the 
rewarding or reinforcing properties of ethanol.    
1-2-4-2. Direct and indirect effects on VTA-DA cell excitation 
Acute ethanol has been shown to increase the firing rate of DA neurons in 
the VTA both in vivo (Gessa et al., 1985) and in vitro (Brodie et al., 1990).  The 
latter study demonstrated a dose-dependent increase in spontaneous firing rate 
that was assumed to be largely attributable to a direct postsynaptic effect since 
the recordings were conducted in low calcium, high magnesium conditions to 
block neurotransmitter release.  Additionally, the firing rate of acutely dissociated 
VTA-DA neurons was also enhanced by ethanol demonstrating that ethanol still 
enhances DA neuron excitability even in the absence of synaptic input (Brodie et 
al., 1999b).   The ethanol enhancement in firing frequency may be due to a 
decrease in the after-hyperpolarization (AHP) amplitude and/or an enhancement 
in the Ih, both important modulators in determining the inter-spike interval (Brodie 
and Appel, 1998).  These authors later demonstrated that, in Fisher-344 rats, 
block of Ih with external cesium or ZD7288 did not modulate ethanol-
enhancement of VTA-DA firing rate (Appel et al., 2003).  However, in C57BL/6J 
mice, ethanol enhances Ih and may contribute to the excitatory effects on VTA-
DA firing (Okamoto et al., 2006), thus suggesting that the involvement of Ih in 
ethanol-enhancement of DA excitability differs across species.  This 
phenomenon was examined again by Brodie and colleagues and they did not 
observe an effect of Ih block on the peak excitatory effect of ethanol on firing rate 
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in C57 and DBA mice; however, in the presence of ZD7288 ethanol produces an 
inhibitory effect on firing rate immediately following an excitatory response 
(McDaid et al., 2008).  Additionally, block of SK-type of calcium-dependent K+ 
current did not affect VTA-DA neuron firing rate, but did potentiate the ethanol-
enhancement (Brodie et al., 1999a).  These results suggest that a reduction in 
the SK current, which contributes to the AHP, does not contribute to the 
excitatory effects of ethanol on DA firing but rather the amount of SK current 
determines the ethanol sensitivity of these neurons.  Other ethanol targets that 
may contribute to the enhancement in firing include a quinidine-sensitive delayed 
rectifier K+ current (Appel et al., 2003) and the voltage-gated K+ current, IM 
(Koyama et al., 2007).   
Upon ingestion, ethanol is metabolized to acetaldehyde (ACD) in the 
periphery by gastric and liver alcohol dehydrogenase (ADH) and in the CNS via a 
brain catalase/H2O2 system. One group contends that the excitatory effect of 
ethanol on the mesolimbic system is not a direct effect of ethanol per se, but 
rather due to an interaction with ACD (Melis et al., 2007).  The authors 
demonstrated that ethanol-induced conditioned place preference is prevented 
with pre-treatment with 4-methyl-pryazole (4-MP), which blocks peripheral 
metabolism of ethanol to ACD.  The authors also observed that the ethanol-
induced increase in DA release in the NAc is blocked with 4-MP pre-treatment 
and local administration of ACD to the VTA increases DA release as measured 
via microdialysis.  Additionally, application of ACD increased the firing rate of 
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VTA-DA neurons in vitro; moreover, co-application of 3-aminotriazole, a catalase 
inhibitor, blocked the ethanol-induced increase in DA firing rate.  The authors 
further contend that the excitatory effects of ACD on firing rate are mediated via 
activation of Ih and inhibition of A-type K
+ channels. 
1-2-5. Neurotransmitter receptors 
1-2-5-1. GABA receptors 
  GABA is the main inhibitory neurotransmitter in the adult central nervous 
system.  There are three GABA receptors: GABAA, GABAB and GABAC.  GABAA 
and GABAC receptors are ligand-gated ion channels permeable to monovalent 
anions, such as Cl- and HCO3
-, and mediate fast synaptic inhibition.  The 
receptors are part of a superfamily of cys-loop ligand-gated ion channels which 
includes nicotinic acetylcholine, glycine and 5-HT3 receptors.  The GABAA 
receptor contains five subunits, with some containing several isoforms (α1-6, β1-3, 
γ1-3, δ, ε, θ, π, ρ1-3) (Barnard et al., 1998).  The most common receptor subtype 
contains two α, two β and one γ subunits in the following arrangements: α1β2γ2, 
α2β3γ2 and α3β3γ2 (Benke et al., 1994; Sigel et al., 2006).  Under typical 
physiological conditions, activation of GABAA receptors results in a flux of Cl
- ions 
into the cell, hyperpolarizing and thus decreasing the excitability of the cell.  
However, conditions do arise when GABAA activation can depolarize the 
membrane.  GABAA receptors are located at synaptic and extrasynaptic 
locations.  γ2-containing receptors are expressed primarily at the synapse 
(Somogyi et al., 1996; Essrich et al., 1998) and mediate fast or „phasic‟ inhibition.  
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δ-containing receptors, which associate primarily with α4/6 and β2/3 subunits are 
expressed exclusively at extrasynaptic locations (Nusser et al., 1998) and 
mediate persistent or „tonic‟ inhibition as a result of GABA-spillover from the 
synapse (Kaneda et al., 1995).   
GABAA receptors are present on VTA-DA neurons and GABA release 
tonically inhibits these neurons (Yim and Mogenson, 1980; Johnson and North, 
1992a; Johnson and North, 1992b; Westerink et al., 1996).  In the SNc and VTA, 
DA neurons contain the α2-4, β1/3 and γ2 receptor subunits (Okada et al., 2004), 
thus suggesting that GABAA receptors in the midbrain are localized primarily to 
synaptic sites mediating phasic inhibition.  Interestingly, some reports suggest 
the majority of GABAA receptors are expressed on GABAergic cells and 
activation of these receptors results in disinhibition, rather than inhibition, of DA 
neurons in the VTA (Kalivas et al., 1990; Churchill et al., 1992; Xi and Stein, 
1998; Laviolette and van der Kooy, 2001; Doherty and Gratton, 2007).   
Metabotropic GABAB receptors are heterodimers composed of two 
subunits (GB1 and GB2) and belong to the class III group of G protein-coupled 
receptors (GPCRs).  GABAB receptors are located at presynaptic and 
postsynaptic sites (Misgeld et al., 1995).  Activation of postsynaptic GABAB 
receptors decreases excitability via opening of a Gi protein-coupled inward 
rectifying K+ channel (GIRK).  Activation of presynaptic GABAB receptors inhibits 
neurotransmitter release via inhibition of voltage-gated Ca2+ channels (VGCCs).  
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GABAB receptors are located at pre- and postsynaptic sites in the VTA 
with presynaptic GABAB receptor activation resulting in a decrease in GABA 
release (Melis et al., 2002).  However, some argue that the majority of GABAB 
receptors are at postsynaptic sites on DA cells (Xi and Stein, 1998) and 
activation of these receptors with baclofen decreases DA output to the NAc 
(Westerink et al., 1996; Amantea and Bowery, 2004).  GIRK-linked GABAB 
receptors are expressed on both GABAergic and DA cells in the VTA (Cruz et al., 
2004).  In that study, the authors demonstrated that GABAergic and DA cells 
exhibit cell-specific expression of GIRK subunits which have different coupling 
efficacies (EC50) for baclofen.  As a result, low baclofen doses inhibit GABAergic 
neurons (low EC50) and high baclofen doses inhibit DA neurons.  Thus due to 
differential expression of GABAA and GABAB receptors within the VTA there 
exists the potential for differential involvement of these receptors in reward and 
reinforcement. 
1-2-5-1-1. Ethanol and GABAA receptors 
 Ethanol intoxication and GABAA receptor activation produce sedative and 
anxiolytic states which led many to believe that ethanol exerted its action on the 
CNS via direct interactions with postsynaptic GABAA receptors.  Supporting 
evidence for this theory has emerged over the past few decades, although with 
mixed results (Mihic, 1999; Criswell and Breese, 2005).  Discrepancies between 
studies in the effects of ethanol on GABAA receptor function can be due to a 
variety of reasons including, but not limited to: brain regions studied; 
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methodological factors; in vitro preparation used; electrophysiological recording 
configuration; and concentration of ethanol used (Weiner and Valenzuela, 2006).   
A major issue at the center of debate regarding ethanol sensitivity of 
postsynaptic GABAA receptors concerns the exact subunit composition of the 
channel.  Synaptic localization of GABAA receptors is subunit-dependent; γ-
containing receptors are localized primarily to the synapse and mediate phasic 
inhibition whereas δ-containing receptors are primarily extrasynaptic and mediate 
tonic inhibition.  Early studies using electrophysiological methods initially 
demonstrated a likely role for ethanol in potentiating γ-containing GABAA 
receptor function.  In studies using oocytes (Wafford et al., 1991) and mouse 
L(tk-) cells (Harris et al., 1995), ethanol was shown to enhance GABAA receptor 
function, but only in those receptors containing γ2L subunits.  Additionally, ethanol 
(1-50 mM) enhanced GABAA mediated currents in cultured mouse hippocampal 
and rat cortical neurons (Reynolds et al., 1992).  However, many later studies 
failed to demonstrate any GABAA receptor sensitivity to ethanol at physiological 
concentrations (Criswell and Breese, 2005), thus fueling the debate regarding the 
role of postsynaptic GABAA receptors in mediating the physiological effects of 
ethanol.  It has been shown that δ-containing GABAA receptors appear to be 
sensitive to low ethanol concentrations (<30 mM) (Sundstrom-Poromaa et al., 
2002; Wallner et al., 2003).  Additionally, Wallner et al (2003) demonstrated that 
γ-containing recombinant receptors were relatively insensitive to ethanol at 
concentrations below 100 mM.  Then again, several groups have been unable to 
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replicate the sensitivity of δ-containing GABAA receptors to low ethanol 
concentrations (Borghese et al., 2006; Yamashita et al., 2006), thus further 
muddling the literature concerning the direct postsynaptic GABAmimetic action of 
ethanol (Santhakumar et al., 2007). 
1-2-5-1-2. Ethanol and GABA release 
 Although there are discrepancies regarding the postsynaptic effects of 
ethanol, there is a general agreement that acutely administered ethanol 
facilitates presynaptic GABA release in most, but not all brain regions (Siggins et 
al., 2005; Weiner and Valenzuela, 2006).  Surprisingly, the notion that ethanol 
could modulate GABA release went largely unexplored after early reports in the 
1980s demonstrated an ethanol-enhancement of postsynaptic GABAA receptor 
function.  Nearly 20 years would pass before the emergence of clear evidence of 
a potentiating effect of ethanol on presynaptic GABA release.  Several 
electrophysiological methods can be used to detect changes in neurotransmitter 
release.  Two methods commonly used for in vitro slice preparations include the 
analysis of changes in quantal, miniature (action potential independent; 
tetrodotoxin-insensitive) and spontaneous (action potential-dependent; 
tetrodotoxin-sensitive) inhibitory postsynaptic currents (m/sIPSCs).  A change in 
the frequency of m/sIPSCs reflects a change in the number of release events; a 
change in the amplitude of m/sIPSCs represents a change in postsynaptic 
receptor sensitivity.  Another method to study neurotransmitter release is by 
analyzing the change in the ratio of paired evoked synaptic potentials (paired-
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pulse ratio; PPR).  A common non-electrophysiological method involves the 
direct measurement of neurotransmitter levels via microdialysis in vivo. 
1-2-5-1-2-1. Hippocampus  
 The hippocampus is an important component of the mesolimbic system 
and is critically involved in learning and memory.  Recordings from CA1 
pyramidal neurons in the hippocampus demonstrated that ethanol (50 mM) 
increased the frequency but not amplitude of GABAA sIPSCs (Carta et al., 2003).  
Additionally, ethanol enhanced the function of presynaptic GABAB autoreceptors 
which masked the ethanol-enhancement of GABAA IPSCs on CA1 pyramidal 
neurons (Ariwodola and Weiner, 2004).  Notably, ethanol (80 mM) enhanced 
both the frequency and amplitude of GABAA-mediated sIPSCs, however, only the 
frequency was further potentiated in the presence of a GABAB receptor 
antagonist.  Acute ethanol (100 mM) application also increased the frequency of 
GABAA mIPSCs recorded from pyramidal neurons, thus suggesting that ethanol 
acts on some presynaptic site to directly facilitate GABA release from these 
terminals (Sanna et al., 2004).  The authors also observed a biphasic effect of 
ethanol on mIPSC amplitude that showed some developmental interactions.  
Ethanol (60 mM) increased the frequency of sIPSCs from CA1 neurons more so 
in adult versus juvenile rats, however there is no age discrepancy regarding 
ethanol enhancement of mIPSC frequency (Li et al., 2006).  In CA1 neurons and 
dentate gyrus granule cells low concentrations of ethanol (30 mM) had no effect 
on sIPSC frequency or amplitude (Wei et al., 2004).  Overall, at high 
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concentrations, ethanol application reliably enhances GABA release, however, in 
only a few studies are there any noticeable effects on postsynaptic GABAA 
receptor sensitivity.          
1-2-5-1-2-2. Amygdala 
 The amygdala is also part of the mesolimbic system and serves as a 
crucial brain region involved in the emotive states associated with drug use and 
abuse (Koob et al., 1998).   In a mechanically isolated neuron/bouton preparation 
from the BLA, ethanol potentiated action potential-independent GABA release 
with no effect on postsynaptic GABAA receptor function (Zhu and Lovinger, 
2006).  In the rat central nucleus of the amygdala (CeA), ethanol (11-66 mM) 
potentiated GABAergic transmission at both pre- and postsynaptic sites (Roberto 
et al., 2003).  Unlike in the hippocampus (Ariwodola and Weiner, 2004) and the 
BLA (Silberman et al., 2009), ethanol enhancement of GABA release in the CeA 
was not modulated by GABAB receptor activation. Microdialysis studies have 
shown an increase in dialysate GABA levels in the CeA after in vivo ethanol 
administration in both naïve and chronic ethanol treated rats (Roberto et al., 
2004).  The mechanism for ethanol enhancement of GABA release in the mouse 
CeA is believed to be mediated via presynaptic corticotropin-releasing factor-1 
(CRF1) receptors.  Perfusion of CRF and ethanol onto CeA neurons produced a 
decrease in the PPR of evoked IPSCs, thus indicating an increase in GABA 
release (Nie et al., 2004).  These effects were blocked in CRF1 knock-out mice 
and in wild-type mice in the presence of CRF1 antagonists.  Another study 
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confirmed these findings demonstrating that ethanol and CRF application 
enhanced the frequency, but not amplitude, of GABAA mIPSCs and this was 
blocked with a CRF1 receptor antagonist (Nie et al., 2009).  Since CRF and 
GABA co-localize in these neurons, ethanol may be acting to increase CRF 
release or CRF1 receptor activation which then enhances GABA release.  
Additionally, protein kinase C (PKC) ε is an integral factor in the CRF1 receptor-
mediated increase in GABA release in the CeA (Bajo et al., 2008).  Lastly, 
ethanol enhancement of GABA release in the CeA is also regulated by delta-
opioid receptors (DORs) (Kang-Park et al., 2007).  Ethanol enhancement of 
GABA release in DOR knock-out mice or in the presence of DOR antagonists 
was greater than in wild-type mice.  Thus, endogenous opiate release negatively 
modulates spontaneous and ethanol-induced GABA release in the CeA.    
1-2-5-1-2-3. Cerebellum 
 The cerebellum plays an important role in coordination and motor control 
and the ataxic effects of intoxication may be attributable to ethanol actions in this 
brain region.  Ethanol (20-100 mM) increased GABA release, both phasic and 
tonic, from Golgi cells onto cerebellar granule cells via an enhancement in the 
firing rate of the Golgi cells (Carta et al., 2004).  However, there was no change 
in sIPSC or evoked IPSC amplitude in the presence of ethanol, suggesting a lack 
of postsynaptic GABAA receptor sensitivity to ethanol.  Additionally, ethanol (25-
100 mM) enhanced mIPSC frequency, but not amplitude, as recorded from 
cerebellar Purkinje neurons (Ming et al., 2006).  When both GABA and glutamate 
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signaling were blocked however, ethanol enhanced the firing rate of Purkinje 
neurons.  Taken together, these findings suggest that ethanol has dual actions to 
increase inhibitory drive while also increasing postsynaptic excitability.  Ethanol 
acts directly at the presynaptic terminals synapsing onto Purkinje neurons to 
enhance GABA release.  The ethanol enhancement of GABA release was shown 
to be dependent on calcium release from ryanodine and inositol-1,4,5- 
triphosphate- (IP3) sensitive intracellular calcium stores (Kelm et al., 2007) as 
well as activation of protein kinase A (PKA) (Kelm et al., 2008).  Overall, ethanol 
enhances GABA release, albeit via different mechanisms, onto cerebellar 
neurons with no discernible effect on postsynaptic GABAA receptor sensitivity. 
1-2-5-1-2-4. VTA and SN 
 Given the important role of the midbrain in alcohol addiction, there are 
surprisingly few studies exploring the role of ethanol modulation of GABA release 
in the VTA.  The first study to measure the effect of ethanol on GABA release in 
this brain region demonstrated that 24 hours after a single injection of ethanol in 
mice, there was a long-lasting potentiation of GABA release that is believed to be 
a manifestation of a long-lasting effect of acute ethanol (Melis et al., 2002; Wanat 
et al., 2008).  Conversely, Ye and colleagues recently reported that ethanol (10-
40 mM) may have differential effects on VTA action potential-dependent GABA 
release.  Although under control conditions ethanol decreased GABA release, an 
increase in sIPSC frequency was observed in the presence of saturating 
concentrations of the MOR agonist DAMGO (Xiao and Ye, 2008).  Thus DAMGO 
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application may silence VTA interneurons via activation of somatic and dendritic 
MORs thereby unmasking a separate stimulatory effect of ethanol on other 
GABAergic inputs.  Ye and colleagues also show that ethanol decreased the 
firing rate of GABA interneurons (Xiao et al., 2007).  Steffensen and colleagues 
demonstrated an ethanol inhibition of interneuron excitability believed to be 
mediated through inhibition of NMDA receptors (Stobbs et al., 2004).  However, 
they also demonstrated that low dose intravenous ethanol (0.01-0.03 g/kg) 
enhanced VTA-GABA neuron firing rate in rats (Steffensen et al., 2009).  The 
authors contend that in the latter study, ethanol enhanced dopamine release 
which then acted to excite local GABA interneurons.  In the substantia nigra pars 
reticulata (SNr), ethanol (100 mM) enhanced GABAA mIPSC frequency (Criswell 
et al., 2008).  They also observed that a lower dose (50 mM) significantly 
increased mIPSC frequency in the presence of a GABAB antagonist, suggesting 
that, like in the hippocampus (Ariwodola and Weiner, 2004), negative feedback 
by GABAB receptor-mediated auto-inhibition can modulate the excitatory effect of 
ethanol at these terminals.  Thus, conflicting results regarding the effects of 
ethanol on GABA release in the VTA demands the need for further investigation.    
1-2-5-1-2-5. Other brain regions 
Ethanol has been demonstrated to enhance GABA release onto medium 
spiny neurons in the NAc (Weiner and Valenzuela, 2006), spinal cord 
motoneurons (Cheng et al., 1999; Ziskind-Conhaim et al., 2003) and brain stem 
motoneurons (Sebe et al., 2003).  However, ethanol did not enhance GABA 
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release in the thalamus (Jia et al., 2008), lateral septum (Criswell et al., 2008) or 
cortex (Moriguchi et al., 2007; Criswell et al., 2008). 
 1-2-5-2. 5-HT2C receptors 
Serotonin (5-Hydroxytryptamine, 5-HT) is a widely distributed 
neurotransmitter throughout the mammalian CNS.  5-HT1 through 5-HT4 are the 
four major receptor families with defined functions, with each family expressing 
multiple subtypes.  5-HT1 and 5-HT4 receptors inhibit and activate adenylyl 
cyclase, respectively.  5-HT2 receptors are coupled to PLC activation and 
generation of IP3 and diacylglycerol.  The 5-HT3 receptor is unique in being the 
only monoamine neurotransmitter receptor that functions as a ligand-gated ion 
channel permeable to both Na+ and K+ ions. The 5-HT2C receptor (5-HT2CR) 
subtype is a Gq protein-coupled receptor that facilitates PLC-mediated IP3 
accumulation and release of calcium from intracellular stores (Conn et al., 1986).  
This receptor is predominantly expressed in the choroid plexus but is also found 
in the midbrain with evidence showing 5-HT2CR mRNA localized to GABAergic 
neurons of the SN (Eberle-Wang et al., 1997).  Additionally, this receptor is 
expressed on both synaptic terminals and cell soma of VTA-GABA neurons of 
the VTA though it has also been reported to occur on DA neurons as well (Bubar 
and Cunningham, 2007).     
Serotoninergic afferents from the midbrain raphe nuclei innervate both DA 
and GABAergic neurons of the VTA (Herve et al., 1987) and thus may influence 
DA output from the VTA.  Indeed, electrophysiological evidence indicates that 5-
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HT reuptake blockade inhibits VTA-DA firing suggesting that a predominant 
action of 5-HT in the VTA is inhibitory and may involve activation of GABAergic 
neurons (Di Mascio et al., 1998).  This contention is supported by the 
observations that 5-HT2CR activation inhibits VTA-DA neuron firing (Di Matteo et 
al., 2000) and decreases DA output to the frontal cortex, striatum and NAc 
(Gobert et al., 2000).  Activation of the IP3-calcium pathway on GABAergic soma 
or terminals may result in enhancement of GABA release.  
Methylenedioxymethamphetamine („ecstasy‟) increases GABA release in the 
VTA through a 5-HT2CR-dependent mechanism (Bankson and Yamamoto, 2004).  
Additionally, local and systemic administration of the 5-HT2CR agonist Ro-60-
0175 was observed to stimulate GABA release in the SN (Invernizzi et al., 2007).  
Furthermore, activation of these receptors in the dorsal raphe nucleus inhibits 5-
HT containing neurons via activation of local GABAergic neurons (Boothman et 
al., 2006).   
1-2-5-2-1. Ethanol and 5-HT 
No in vitro electrophysiological studies have previously explored the role 
of 5-HT2CRs specifically in the actions of ethanol.  However, 5-HT2CRs may exert 
tonic control over the motivational aspects of ethanol drinking behavior.  One 
study found that activation of 5-HT2CRs decreased ethanol self-administration 
whereas inhibition of these receptors had the opposite effect (Tomkins et al., 
2002).  Furthermore, ethanol increased 5-HT release in the NAc (Yoshimoto et 
al., 1992) and prevented 5-HT reuptake in the hippocampus (Daws et al., 2006).  
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Thus, it is apparent that there is a 5-HT/ethanol interaction in the CNS and given 
the modulatory role of 5-HT2CRs in the midbrain, further investigation is 
necessary to uncover a potential ethanol interaction in the VTA.   
1-2-5-3. Opioid receptors 
 Opioid receptors are GPCRs with multiple transduction mechanisms.  
Three known classes of opioid receptors include mu, delta and kappa which 
show high affinity for the endogenous opioids beta-endorphin, enkephalin and 
dynorphin, respectively (Zollner and Stein, 2007).  All three receptors exhibit 
generally similar mechanisms in that they are coupled to Gi/o proteins.  These 
receptors exhibit multiple functions and have been demonstrated to inhibit 
neurotransmitter release (Schoffelmeer et al., 1988), inhibit adenylyl cyclase 
(Sharma et al., 1977), activate K+-dependent calcium channels (North et al., 
1987), stimulate PLC (Murthy and Makhlouf, 1996) and inhibit VGCCs (Morikawa 
et al., 1995).  MORs are localized presynaptically to GABAergic terminals in the 
VTA (Svingos et al., 2001) and activation of these receptors disinhibits DA 
neurons (Johnson and North, 1992a; Margolis et al., 2003).  This is likely due to 
a reduction in GABA release via MOR-mediated inhibition of the secretory 
process at the nerve terminal of GABAergic cells (Bergevin et al., 2002).  KORs 
are also located in the VTA and activation of these receptors directly inhibits DA 
neuron activity (Margolis et al., 2003).  Additionally, activation of MORs and 
KORs in the VTA inhibits glutamatergic input onto both DA and GABAergic 
neurons (Margolis et al., 2005).  Activation of DORs in the VTA decreases 
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frequency, but not amplitude of m/sIPSCs recorded from VTA-DA neurons thus 
suggesting that DORs are also located presynaptically on GABAergic terminals 
(Margolis et al., 2008).  It should be noted however, this effect is only seen in 
drinking animals and not in ethanol-naïve animals.    
1-2-5-3-1. Ethanol and opioids 
The rewarding and reinforcing properties of ethanol have been linked to 
various opiate receptor subtypes in the mesolimbic system.  Acute ethanol 
exposure has been demonstrated to increase endogenous beta-endorphin levels 
in a variety of brain structures (Gianoulakis and Barcomb, 1987; de Waele and 
Gianoulakis, 1993; Olive et al., 2001) including the VTA (Rasmussen et al., 1998; 
Jarjour et al., 2009).  Ethanol also increases levels of enkephalins and 
dynorphins but results between studies are inconsistent (Jarjour et al., 2009).   
Numerous behavioral studies suggest that the opioidergic system 
modulates ethanol drinking behavior.  Naltrexone and naloxone, two antagonists 
with affinity to all three opioid receptor subtypes, reduce ethanol consummatory 
behaviors (Gonzales and Weiss, 1998; Shoemaker et al., 2002; Stromberg et al., 
2002).  However, there is more consistent evidence demonstrating MOR 
modulation of ethanol intake behaviors.  The use of selective MOR antagonists 
or genetic deletion of MORs reduces ethanol drinking (Honkanen et al., 1996; 
Krishnan-Sarin et al., 1998; Stromberg et al., 1998; Kim et al., 2000; Hall et al., 
2001; Hyytia and Kiianmaa, 2001; Mhatre and Holloway, 2003; Lasek et al., 
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2007; Margolis et al., 2008); however, these results are not universal (Le et al., 
1993).   
The precise role of DORs and KORs in ethanol consummatory behaviors 
is less clear with variable results across studies and animal models used.  For 
example, some studies have demonstrated a lack of an effect of DOR 
antagonism on ethanol intake (Honkanen et al., 1996; Stromberg et al., 1998; 
Ingman et al., 2003).  Alternatively, other studies have shown that antagonism of 
DORs reduced ethanol intake (Le et al., 1993; Krishnan-Sarin et al., 1995; June 
et al., 1999; Kim et al., 2000; Hyytia and Kiianmaa, 2001).  DOR antagonism was 
recently reported to produce a long-lasting decrease in ethanol consumption in 
high- but not low-ethanol drinking rats (Nielsen et al., 2008).  Conversely, one 
study demonstrated that DOR antagonism in the VTA increased ethanol 
consumption in low-drinking rats whereas activation reduced consumption 
(Margolis et al., 2008).  The authors contend that chronic ethanol consumption 
upregulates DOR function which acts to decrease GABA release onto DA 
neurons.  There is general agreement that KOR activation decreases ethanol 
drinking (Sandi et al., 1988; Nestby et al., 1999; Lindholm et al., 2001); however, 
some studies have shown KOR knock-out mice display decreased drinking 
(Kovacs et al., 2005) and KOR antagonism reduced ethanol drinking in ethanol-
dependent rats only (Walker and Koob, 2008).  Additionally, mice lacking 
preprodynorphin, the precursor to dynorphins which selectively bind KORs, show 
reduced ethanol consumption (Blednov et al., 2006).   
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The reason for the variability between studies is unclear; however, further 
work with more selective opioid receptor antagonists may help to delineate the 
precise roles of the different receptors in the motivational responding and 
reinforcing properties of ethanol drinking.  Additionally, variability with species 
and strain of the animals used in addition to the method and location of drug 
delivery could explain some of the differences between studies.  In spite of this, 
there does appear to be strong consensus in the role of MORs in mediating 
some of the reinforcing properties of ethanol. 
Modulation of DA release to the NAc may explain the effect of opioids to 
regulate ethanol consummatory behaviors.  Ethanol intake increases the output 
of VTA-DA neurons, and this output is concurrently modulated by opioidergic 
systems.  Recent evidence suggests that the ethanol-induced increase in 
dopamine release to the NAc is modulated by MORs (Job et al., 2007).  The 
authors demonstrated that pharmacological blockade with the MOR-selective 
antagonist, naloxonazine, or genetic deletion of MORs reduced the ethanol-
enhancement in DA release, suggesting that MORs positively regulate DA 
activity in the VTA.  Indeed, MORs are localized presynaptically to GABAergic 
terminals in the VTA (Svingos et al., 2001) and activation of these receptors 
disinhibits DA neurons (Johnson and North, 1992a; Margolis et al., 2003).  In 
light of this evidence, ethanol may act to increase endorphin release into the VTA 
and thus disinhibit DA neurons thereby constituting a potential mechanism in 
MOR regulation of ethanol drinking.  Interestingly, in the CeA, ethanol increased 
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GABA release and this effect was enhanced in DOR knock-out mice and in the 
presence of DOR antagonists (Kang-Park et al., 2007).  That study suggests that 
endogenous opiate release negatively modulates spontaneous and ethanol-
induced GABA release in the CeA; thus, a similar scenario may exist in the VTA 
and may thus have implications for the therapeutic utility of naltrexone. 
1-3. Calcium and neurotransmitter release  
1-3-1. Role of extracellular calcium and VGCCs 
 Action potential propagation down to the presynaptic terminal activates 
VGCCs near neurotransmitter release machinery and the subsequent rise in 
local calcium concentration in this region activates a cascade of events resulting 
in the release of neurotransmitter quanta.  N- and P/Q-type channels are those 
predominantly involved in transmitter release (Wheeler et al., 1994), although  L-
type channels have been reported to regulate spontaneous GABA release as 
well (Rhee et al., 1999).  Although quantal neurotransmitter release is typically 
measured electrophysiologically in the presence of tetrodotoxin (TTX), some 
neurons express TTX-insensitive Na+ channels that mediate a subthreshold 
depolarizing current that may be capable of activating VGCCs allowing for 
calcium influx.  A TTX-insensitive current is found in GABAergic neurons of the 
SNr (Atherton and Bevan, 2005) and could exist in VTA, thus the resultant 





1-3-1-1. Ethanol and VGCCs 
 It is widely accepted that ethanol inhibits some VGCCs and this may 
impart some of the physiological effects of ethanol intoxication (Walter and 
Messing, 1999).  Ethanol decreased calcium influx through VGCCs in cultured 
superior cervical ganglion (SCG) neurons (Xiao et al., 2005).  In 
pheochromocytoma (PC12) cells, ethanol inhibited dihdyropyridine-sensitive L-
type VGCCs but had little to no effect on ω-conotoxin-sensitive N-type VGCCs 
(Mullikin-Kilpatrick and Treistman, 1995).  In the hippocampus, ethanol was 
shown to inhibit glutamate release via inhibition of N/P/Q-type VGCCs (Maldve et 
al., 2004) as well as L-type VGCC mediated synaptic plasticity of excitatory 
transmission (Hendricson et al., 2003).  Ethanol has also been demonstrated to 
inhibit voltage-gated Na+ channels (VGSCs) in cultured SCG neurons (Xiao et 
al., 2008)  and recombinant VGSCs expressed in xenopus oocytes, specifically 
those channels containing the Nav1.2 α-subunit (Shiraishi and Harris, 2004).   
1-3-2. Role of IP3- and ryanodine-sensitive intracellular calcium stores  
 Ryanodine- and IP3-sensitive intracellular calcium stores play a role in 
regulating transmitter release in several mammalian neurons.  Ryanodine-
sensitive calcium stores modulate both action potential-dependent and 
independent GABA release from presynaptic nerve terminals in the cerebellum 
(Llano et al., 2000; Galante and Marty, 2003) and spontaneous GABA release in 
the hippocampus of neonates (Savic and Sciancalepore, 1998).  In hippocampal 
presynaptic boutons, ryanodine-sensitive Ca2+-induced Ca2+ release (CICR) 
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controls approximately half of all transmitter release (Emptage et al., 2001).  
Presynaptic calcium stores also contribute to GABA release onto cerebellar 
Purkinje neurons in the mouse (Bardo et al., 2002).  In retinal amacrine cells, 
calcium released from IP3-sensitive stores, but not ryanodine, controls 
spontaneous transmitter release (Warrier et al., 2005).  Likewise, spontaneous 
GABA release onto Meynert neurons in the rat are partially influenced by IP3-
senstive calcium stores (Rhee et al., 1999).  In the striatum, dopamine 
transmission is modulated by CICR through IP3-sensitive calcium stores (Zhu et 
al., 2004).  Ryanodine and IP3 receptor-dependent calcium mobilization has been 
demonstrated in DA neurons of the VTA in rats (Morikawa et al., 2003).  
Furthermore, ryanodine receptors are present in GABAergic nerve terminals of 
the SNr, a neighboring region of the VTA (Yanovsky et al., 2005).   
1-3-2-1. Ethanol and intracellular calcium stores 
 Although typically reducing the influx of calcium through VGCCs, ethanol 
stimulates calcium release from intracellular stores.  Ethanol increased calcium 
release from IP3-senstive stores in brain microsomes (Daniell and Harris, 1989).  
In cultured hippocampal neurons ethanol increased calcium release from a single 
pool containing both ryanodine and IP3 receptors (Mironov and Hermann, 1996).  
Ethanol dose-dependently increased basal intracellular calcium levels in primary 
cultured SCG neurons as well (Xiao et al., 2005).  Most importantly, calcium 
release from presynaptic IP3- and ryanodine-sensitive internal stores is 
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necessary for ethanol potentiation of GABA release onto Purkinje neurons in the 
cerebellum (Kelm et al., 2007; Kelm et al., 2008).   
1-4. Hypothesis and Aims 
Ethanol enhances opioid release in the VTA and resultant activation of 
MORs present on GABAergic interneurons should theoretically disinhibit VTA-DA 
neurons.  Disinhibition via a decrease in GABA release could be one mechanism 
by which ethanol enhances VTA-DA neuron activity.  However, preliminary data 
demonstrated an ethanol-enhancement in GABA release onto VTA-DA neurons.  
Therefore, the overarching hypothesis of the current proposal states that ethanol 
enhancement of GABA transmission in the VTA may be important for modulating 
alcohol drinking behavior and alcohol dependence.  Two working hypotheses 
arise from this overarching hypothesis and preliminary work and will be 
investigated here: (1) ethanol-enhanced GABA release is mediated via release of 
calcium from internal stores through a 5-HT2C receptor-dependent mechanism 
and (2) the ethanol-induced increase in GABA release limits the stimulatory 
effect of ethanol on VTA-DA firing rate and is masked by endogenous opioid tone 
acting on presynaptic MORs.  The specific aims are: 
Aim 1.1:  Investigate the relative role of extracellular calcium on the ethanol-
induced enhancement in GABA release.  Utilizing whole-cell voltage-clamp 
recordings of mIPSCs from VTA-DA neurons, we will investigate the role of 
extracellular calcium on ethanol-elicited GABA release in the VTA. 
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Aim 1.2:  To test the hypothesis that ethanol-enhancement in presynaptic GABA 
release is mediated via calcium release from intracellular stores.  Utilizing whole-
cell voltage clamp recordings of mIPSCs from VTA-DA neurons, we will 
investigate the role of intracellular calcium stores on ethanol-elicited GABA 
release. 
Aim 1.3:  To test the hypothesis that ethanol increases synaptic GABA release 
through a 5-HT2C receptor-dependent mechanism.  Utilizing whole-cell voltage-
clamp recordings of mIPSCs from VTA-DA neurons, we will investigate the role 
of the 5-HT2C receptor in ethanol-elicited GABA release in the VTA. 
Aim 2.1:  To test the hypothesis that the ethanol-induced increase in synaptic 
GABA release limits the ethanol-enhancement in VTA-DA neuron activity.  
Utilizing cell attached current-clamp recordings we will investigate GABAA 
receptor-dependent regulation of VTA-DA neuron firing rate and interactions with 
ethanol. 
Aim 2.2:  To test the hypothesis that the ethanol-induced increase in synaptic 
GABA release is modulated by presynaptic µ-opiate receptors.  Utilizing a 
combination of whole-cell voltage-clamp and cell attached current-clamp 
recordings we will investigate MOR-dependent regulation of GABA release, VTA-










Figure 1-1.  Areas of VTA in which recordings were conducted.  A diagram 
representing the approximate location (represented by hatched area) of VTA-DA 
recordings for the experiments of this dissertation.  Abbreviations: IF, 
interfascicular nucleus; ml, medial lemniscus; fr, fasciculus retroflexus; MT, 
medial terminal nucleus of the accessory optic tract; PBP, parabrachial 
pigmented area; PFR, parafasciculus retroflexus area; PN, paranigral nucleus; 
SNc, substantia nigra compacta; SNr, substantia nigra reticulata; SUM, 
supramammillary nucleus.  The PBP, PN and PFR are subregions of the VTA.  In 
an adolescent rat (21-28 days postnatal), the dorsal-ventral plane is 
approximately -4.8 mm from bregma; the anterior-posterior plane is 
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Background: Activation of the dopaminergic (DA) neurons of the ventral 
tegmental area (VTA) by ethanol has been implicated in its rewarding and 
reinforcing effects.  At most central synapses ethanol generally increases 
inhibitory synaptic transmission, however no studies have explored the effect of 
acute ethanol on GABAergic transmission in the VTA. 
Methods:  Whole-cell patch clamp recordings of inhibitory postsynaptic currents 
(IPSCs) from VTA-DA neurons in midbrain slices from young rats. 
Results:  Acute exposure of VTA-DA neurons to ethanol (25-50 mM) robustly 
enhanced GABAergic spontaneous and miniature IPSC frequency while inducing 
a slight enhancement of sIPSC amplitude.  Ethanol (50 mM) enhanced paired-
pulse depression of evoked IPSCs further suggesting enhanced GABA release 
onto VTA-DA neurons.  The frequency of sIPSCs was suppressed by the GABAB 
agonist, baclofen (1.25 M) and enhanced by the antagonist, SCH50911 (20 
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M); however, neither appeared to modulate or occlude the effects of ethanol on 
sIPSC frequency. 
Conclusions:  The present results indicate that ethanol increases postsynaptic 
GABAA receptor sensitivity, enhances action potential-independent GABA 
release onto VTA-DA neurons, and that this effect is independent of GABAB 
auto-receptor inhibition of GABA release. 
2-1. Introduction 
Dopaminergic (DA) neurons of the ventral tegmental area (VTA) constitute 
the central locus of the mesocorticolimbic dopamine system and send projections 
to the nucleus accumbens (NAc), prefrontal cortex, basolateral amygdala and a 
variety of other corticolimbic structures (Albanese and Minciacchi, 1983; Oades 
and Halliday, 1987).  Substantial evidence suggests these VTA-DA projections 
contribute to certain aspects of drug reinforcement and/or reward (Gatto et al., 
1994; Robbins and Everitt, 1996; Wise, 1996; Koob et al., 1998; Schultz, 2002; 
Appel, 2004).  Indeed, ethanol has been shown to increase the firing rate of DA 
neurons in the VTA both in vitro (Brodie et al., 1990) and in vivo (Gessa et al., 
1985).  Ethanol may be acting through direct effects on DA neuron excitability 
(Brodie and Appel, 1998; Brodie et al., 1999b) that are at least partly attributable 
to an increase in the hyperpolarization-activated cation current (Ih) (Okamoto et 
al., 2006). 
In addition to the principal DA neurons, the VTA also contains a major 
population of GABAergic neurons (Grace and Onn, 1989; Johnson and North, 
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1992b; Korotkova et al., 2003).  The GABAergic neurons function importantly as 
local interneurons that regulate the firing of the DA neurons via tonic inhibition 
(Johnson and North, 1992a; Bonci and Malenka, 1999).  The effect of acute 
ethanol on GABAergic transmission has been extensively explored in a variety of 
brain regions (Wan et al., 1996; Roberto et al., 2003; Carta et al., 2004; Nie et 
al., 2004; Weiner and Valenzuela, 2006); however, remarkably, virtually nothing 
is known about the direct effects of acute ethanol on GABAergic transmission in 
the VTA.  One electrophysiological study measured prolonged enhancement of 
GABAergic transmission in mice 24 hours after a single in vivo exposure to 
ethanol (Melis et al., 2002). 
Thus while excitatory actions of ethanol in the VTA have been well-documented, 
the possibility that conventional stimulatory effects of ethanol on GABAergic 
transmission that also may modulate VTA-DA neuronal excitability has not been 
investigated.  To determine whether ethanol modulates GABAergic transmission 
in this brain region, we studied GABAA-mediated IPSCs recorded from VTA-DA 
neurons using conventional whole-cell patch clamp techniques in the presence of 
varying concentrations of ethanol.   
2-2. Materials and Methods   
2-2-1. Slice preparation 
All experiments were carried out in accordance with NIH guidelines.  
Slices used in this study were prepared from Sprague-Dawley rats of both sexes 
(postnatal day 21 to 30).  Rats were anesthetized with halothane, decapitated, 
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and the brain was rapidly removed and placed in ice-cold, oxygenated artificial 
cerebrospinal buffer (aCSF) containing (in mM): 120 NaCl, 25 NaHCO3, 3.3 KCl, 
1.23 NaH2PO4 and 10 dextrose, 95%O2/5%CO2 (all chemicals obtained from 
Sigma, St Louis, MO).  Cutting aCSF also contained 2.4 mM MgSO4 and 1.8 mM 
CaCl2.  Horizontal midbrain slices (200-220 µm) were prepared using a 
vibratome (VT1000S; Leica, Nussloch, Germany).  The slices were then 
maintained at 32ºC in cutting aCSF buffer for a minimum of 60 minutes before 
electrophysiological recordings were performed. 
2-2-2. Electrophysiological recordings  
Slices were transferred to a recording chamber and perfused with 
oxygenated aCSF (30-32ºC) at a flow rate of ~2 ml/min.  Recording aCSF also 
contained 0.9 mM MgSO4 and 2 mM CaCl2.  DA neurons were identified by the 
presence of a large hyperpolarization-induced Ih current (>200 pA) that was 
assayed immediately following break-in by application of a 1.5-s hyperpolarizing 
step from -60 to -110 mV (Johnson and North, 1992b).  Only DA neurons 
identified in this manner from the VTA were used for this study.  Recording 
electrodes were made from thin-walled borosilicate glass (TW 150F-4, WPI, 
Sarasota, Florida, 1.5-2.5 MΩ).  Recording electrodes for whole-cell recordings 
contained (in mM): 135 KCl, 12 NaCl, 0.5 EGTA, 10 HEPES, 2 Mg-ATP, and 0.3 
Tris-GTP, pH 7.3 with KOH (all chemicals obtained from Sigma, St Louis, MO).  
Access resistance was partially compensated and monitored throughout all 
experiments.  Data were collected by an Axon Instruments Model 200B amplifier 
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filtered at 1 kHz and digitized at 10-20 kHz with a Digidata interface using 
pClamp v9.2 (Axon Instruments, Foster City, California).   
Kynurenic acid (1 mM) was used in all whole-cell voltage clamp recordings 
to inhibit AMPA- and NMDA receptor-mediated currents.  All GABA IPSCs were 
inward at a holding potential of -60 mV and completely blocked by application of 
picrotoxin (50 µM).  Miniature IPCSs (mIPSCs) were recorded in the presence of 
0.5 µM tetrodotoxin (TTX) to block action potentials.  Spontaneous IPSCs 
(sIPSCs) were recorded in the absence of TTX.  Following break-in and after a 
stable 5-10 minute baseline (control) recording, drugs were bath-applied through 
the aCSF and a continuous 5-15 minute recording was made to detect any 
changes in m/sIPSC frequency and amplitude.  The number of neurons used per 
each treatment condition is represented as n with only one neuron used per slice.  
A five minute drug wash-on preceded the start of data collection in each 
treatment condition.  A 10-15 minute washout period followed drug application.  
SCH50911 was obtained from Tocris Bioscience, Ellisville, MO.  Baclofen, 
kynurenic acid, and picrotoxin were obtained from Sigma, St. Louis, MO.  TTX 
was obtained from Alomone Labs, Jerusalem, Israel. 
A monopolar tungsten stimulating electrode was placed 50-100 µm rostral 
of the recording electrode for evoked IPSC recordings.  Constant-current pulses 
(100-µs duration, 15–40 pA amplitude) were applied through a stimulus isolation 
unit driven by an analog stimulator (WPI).  Paired-stimuli were delivered every 20 
or 30 sec with an interstimulus interval of 70 msec. 
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2-2-3. Data analysis  
For m/sIPSC recordings, quantal events were detected (60-90 sweeps 
each condition, 5 sec/sweep) and analyzed using Clampfit (pClamp v9.2 
software; Axon Instruments).  Access resistance for most experiments ranged 
from 6 to 20 MΩ and never exceeded 25 MΩ.  To maintain the fidelity of the 
recordings, experiments where access resistance changed (>20% at anytime 
during the experiment) were not included in data analyses.  To accurately 
determine the m/sIPSC amplitude, only those events that were >10 pA were 
accepted for analysis in order to maintain a high signal-to-noise ratio.  Treatment 
and washout groups were normalized to the baseline (control) frequency or 
amplitude and represented as a percentage of the control.  For evoked paired 
stimuli, the ratio between the second and the first IPSCs was calculated and 
averaged for a 10 minute baseline and a minimum 10 minute treatment condition.  
Averaged values for all data sets are expressed as mean ± SEM and were 
compared statistically using two-tailed paired or unpaired student's t test or 
ANOVA/Dunnett C or Tukey HSD post-hoc where mentioned.  Significant 
differences were considered as *p < 0.05 and **p < 0.01.  
2-3. Results 
2-3-1. Baseline parameters of sIPSCs on VTA neurons 
 Data in this study were gathered using whole-cell voltage-clamp from VTA 
neurons that were identified as dopaminergic by the presence of a large Ih 
current (see Materials and Methods).  The GABAA receptor blocker picrotoxin (50 
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µM) completely blocked the sIPSCs, indicating that they were GABA-mediated 
(data not shown, n = 3).  The baseline frequency and amplitude of sIPSCs 
recorded in control conditions from all cells tested across every treatment group 
were 3.89 + 0.30 Hz and 52.01 + 1.31 pA, respectively (n = 52). 
2-3-2. Ethanol enhances GABAergic transmission in the VTA 
 To measure the effect of varying concentrations of ethanol (15- 50 mM; 
legal intoxication is ~17 mM), GABAA-mediated sIPSCs were recorded across 
this range of ethanol concentrations in two separate experiments in separate 
groups of slices: 15 and then 25 mM (Fig. 1), and 25 and then 50 mM (Fig. 2) 
ethanol.  Thus the inherent difficulties of maintaining very long-lasting whole-cell 
recordings for these concentration-response experiments were minimized.  After 
application of ethanol (15 mM), no significant increases in sIPSC frequency (Fig. 
1A, B) and amplitude (Fig. 1A, C) were observed.  However, subsequent 
application of ethanol (25 mM) produced a significant increase in sIPSC 
frequency (Fig. 1A, B) but not amplitude (Fig. 1A, C).   
 In the separate cohort of recordings where 25 mM ethanol was initially 
applied, interesting differences in sIPSC event frequency and amplitude were 
observed (Fig. 2) compared to the effect presented in the previous 15-25 mM 
experiment.  In this instance, application of ethanol (25 mM) did not result in a 
significant increase in either sIPSC frequency or amplitude (Figs. 2C, D).  
However, subsequent application of ethanol (50 mM) to the same neuron 
produced a significant increase in sIPSC frequency (Fig. 2C) and amplitude (Fig. 
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2D).  The distributions of the sIPSC inter-event intervals and amplitude for 
control, ethanol (25, 50 mM) and wash conditions are shown in a sample 
representative neuron (Figure 2E, F).  There was a progressive leftward shift in 
the inter-event interval distribution, indicative of increased GABA release that at 
least partially reversed upon wash (Fig. 2E).  Additionally, there was a 
progressive rightward shift in peak amplitude distribution, indicative of increased 
postsynaptic GABA sensitivity, which partially reversed upon wash (Fig. 2F).  The 
cumulative changes in sIPSC frequency and amplitude recorded at each ethanol 
concentration were pooled from all experiments [15 mM (n = 7), 25 mM (n = 22), 
and 50 mM ethanol (n = 11)] (Fig. 3).  Application of ethanol (25 and 50 mM) 
produced a significant increase above control in frequency (Fig. 3A) and 
amplitude (Fig. 3B).  Ethanol at 15 mM did not produce a significant increase in 
either frequency or amplitude.  No concentration above 50 mM was tested.  It is 
conceivable that the observed ethanol-induced increase in sIPSC amplitude, 
although slight, may result in an apparent increase in sIPSC frequency due to the 
detections of small events under control conditions which were below detection 
threshold (10 pA) and thus not previously detected.  Therefore, we calculated the 
% enhancement induced by ethanol of the number of events for a defined 
recording duration binned across all amplitude ranges.  As shown in Fig. 4C, 
from a neuron which showed a maximal increase in sIPSC frequency (~86% 
above control) ethanol increases the number of events relatively equivalently 
across all amplitude bins. 
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 To investigate further the ethanol-mediated enhancement in presynaptic 
release as demonstrated in the increase in sIPSC frequency, we measured the 
paired-pulse ratio of evoked IPSCs (as described in Materials and Methods) 
before and after application of ethanol (50 mM).  In 5 of 6 VTA-DA neurons, 
application of 50 mM ethanol resulted in a significant enhancement of paired-
pulse depression (PPD), indicative of enhanced GABA release (Fig. 4C).  
Additionally, we measured the decay time of the evoked IPSCs and found that 
ethanol prolonged the decay time constant, τ, indicative of an enhancement, 










      
 
Figure 2-1.  Ethanol (25 mM) potentiates sIPSC frequency.  A. sIPSCs 
recorded from a VTA-DA neuron under control conditions, in the presence of 15 
mM and 25 mM ethanol, and after a washout.  B.  A bar graph representing the 
% change + SEM above control sIPSC frequency for the conditions shown in A.  
Event frequency under control conditions was 4.62 + 0.75 Hz. C.  A bar graph 
representing the % change + SEM above control sIPSC amplitude for the 
conditions shown in A.  Event amplitude under control conditions was 52.82 + 









Figure 2-2.  Ethanol (50 mM) potentiates sIPSC frequency and amplitude.  
A. sIPSCs recorded from a VTA-DA neuron under control conditions, in the 
presence of 25 mM and 50 mM ethanol, and after a washout.  B.  Time course 
for a sample representative neuron under conditions shown in A.  The dotted 
lines represent the average frequency under each condition for that neuron.  C.  
A bar graph representing the % change + SEM above control sIPSC frequency 
for the conditions shown in A.  Event frequency under control conditions was 
5.48 + 0.93 Hz.  D.  A bar graph representing the % change + SEM above control 
sIPSC amplitude for the conditions shown in A.  Event amplitude under control 
conditions was 54.49 + 5.56 pA.  E.  Cumulative probability histogram of sIPSC 
inter-event intervals for epochs from same neuron shown in B.  F.  Cumulative 
probability histogram of sIPSC event amplitudes from the same neuron shown in 
B, E.  (n = 8, * indicates p < 0.05 by ANOVA/Dunnett C post-hoc different from 
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Figure 2-3. Cumulative results show ethanol-induced potentiation of sIPSC 
frequency and amplitude at varying concentrations.  A.  A bar graph 
representing the % change + SEM above control sIPSC frequency in the 
presence of 15 mM, 25 mM, and 50 mM ethanol.  Event frequency under control 
conditions was 4.92 + 0.44 Hz.  B.  A bar graph representing the % change + 
SEM above control sIPSC amplitude for the conditions shown in A.  Event 
amplitude under control conditions was 52.92 + 2.06 pA.  (n = 7 for 15 mM, n = 
22 for 25 mM, n = 11 for 50 mM, * indicates p < 0.05, ** indicates p < 0.01 by 
ANOVA/Dunnett C post-hoc different from control)  C.  A sample cell was 
analyzed that showed a maximal ethanol-induced (50 mM) enhancement in 
sIPSC frequency (~86% above control) to determine the percent change in the 
number of events at their respective amplitude distribution.  The events were 
binned into 5 pA groups, for example, the point at 30 pA represents all events 
>25 and <30 pA.  All events at 105 pA represent those events greater than 100 
pA in size.  The total number of events was 1,148 and 2,135 in control and 
ethanol conditions, respectively, taken from a time course of 5 minutes for each 
condition. (Note: the 300% change in events <15 pA represents an increase from 



















Figure 2-4. Ethanol enhances paired-pulse depression.  A, B. Sample evoked 
IPSC recordings from a VTA-DA neuron prior to (A), and after exposure to 
ethanol (50 mM) (B).  Each trace represents an averaged trace from 8 individual 
traces over a continuous 3.5 minute time period for each condition from a 
representative neuron.  Both recordings exhibit paired-pulse depression (PPD), 
however after exposure to ethanol, the PPD is enhanced.   C.  A bar graph 
representing the paired-pulse ratio (defined as IPSC2/IPSC1) under control 
conditions and in the presence of ethanol (50 mM).  D.  A bar graph representing 
the decay time as measured by the time constant, τ (ms), under control 
conditions and in the presence of ethanol (50 mM).  (n = 5 of 6, * indicates p < 






2-3-3. Ethanol potentiation of sIPSCs does not involve GABAB receptors 
  Activation of GABAB receptors on midbrain GABAergic interneurons 
inhibits GABA release from these neurons (Rohrbacher et al., 1997; Bonci and 
Malenka, 1999), and inhibition of GABAB receptors on hippocampal interneurons 
can increase GABA release (Mott and Lewis, 1991).  Therefore, to test the 
possibility that ethanol may act via presynaptic GABAB receptors to increase 
GABA release, we recorded sIPSCs from VTA-DA neurons in the presence of 
either the GABAB agonist, baclofen, or the antagonist, SCH50911.  In separate 
experiments, sIPSCs were recorded from VTA-DA neurons under control 
conditions followed by bath application of either baclofen (1.25 µM) or SCH50911 
(20 µM), followed again by co-application of baclofen or SCH50911 with ethanol 
(50 mM).  Application of baclofen alone reversibly decreased sIPSC frequency 
(Fig. 5A, B) but not amplitude (Fig. 5A, C).  Subsequent co-application of ethanol 
and baclofen resulted in approximately a 30 percent increase in frequency above 
the baclofen-induced decrease with no significant change in amplitude.  
Application of SCH50911 (20 µM) significantly increased sIPSC frequency (Fig. 
6A, B) with no significant change in amplitude (Fig. 6A, C) with respect to control.  
Subsequent co-application of ethanol and SCH50911 resulted in a 23 percent 
increase in frequency above SCH50911 alone that was reversible upon washout, 
with no apparent change in amplitude.  Therefore, the results displayed in 
Figures 5 and 6 suggest that the ethanol-induced potentiation in sIPSC 
frequency is not affected by addition of a GABAB receptor agonist or antagonist. 
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Figure 2-5.  Baclofen does not inhibit ethanol-induced potentiation of sIPSC 
frequency.  A. sIPSCs recorded from a VTA-DA neuron under control 
conditions, in the presence of 1.25 µM baclofen, 50 mM ethanol with 1.25 µM 
baclofen, and after a washout.  B.  A bar graph representing the % change + 
SEM above control sIPSC frequency for the conditions shown in A.  Event 
frequency under control conditions was 2.36 + 0.23 Hz.  C.  A bar graph 
representing the % change + SEM above control sIPSC amplitude for the 
conditions shown in A.  Event amplitude under control conditions was 49.48 + 
3.41 pA.  (n = 6, ** indicates p < 0.01 by ANOVA/Dunnett C post-hoc different 
from control, *† indicates p < 0.05 by ANOVA/Dunnett C post-hoc different from 




      
Figure 2-6.  SCH50911 does not occlude ethanol-induced potentiation of 
sIPSC frequency.  A. sIPSCs recorded from a VTA-DA neuron under control 
conditions, in the presence of 20 µM SCH50911, 50 mM ethanol with 20 µM 
SCH50911, and after a washout.  B.  A bar graph representing the % change + 
SEM above control sIPSC frequency for the conditions shown in A.  Event 
frequency under control conditions was 1.89 + 0.40 Hz.  C.  A bar graph 
representing the % change + SEM above control sIPSC amplitude for the 
conditions shown in A.  Event amplitude under control conditions was 51.58 + 
2.24 pA.  (n = 6, * indicates p < 0.05 by ANOVA/Tukey HSD post-hoc different 
from control, ** indicates p < 0.01 by ANOVA/Tukey HSD post-hoc different from 
control, *† indicates p < 0.05 by ANOVA/Tukey HSD post-hoc and by paired 
student‟s t test different from SCH50911 alone, *†† indicates p < 0.05 by 
ANOVA/Tukey HSD post-hoc different from wash). 
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2-3-4. Ethanol potentiates GABA release in the VTA 
 In order to further discern whether ethanol potentiates the frequency of 
spontaneous IPSCs by directly enhancing GABA release from presynaptic 
terminals or increasing the excitability of GABAergic interneurons, we recorded 
mIPSCs in the presence of TTX to block action potential-mediated release 
events.  Application of ethanol (50 mM) produced a marked enhancement in 
mIPSC frequency (Fig. 7A, B), but not amplitude (Fig. 7A, C).  A time course plot 
is shown in Fig. 7D to demonstrate the onset of ethanol action.  These results 
support the notion that ethanol is acting presynaptically to enhance GABA 














    
FIGURE 2-7.  Ethanol (50 mM) potentiates mIPSC frequency.  A. mIPSCs 
recorded from a VTA-DA neuron under control conditions, in the presence of 50 
mM ethanol, and after a washout.  B.  A bar graph representing the % change + 
SEM above control mIPSC frequency for the conditions shown in A.  Event 
frequency under control conditions was 2.57 + 0.45 Hz.   C.  A bar graph 
representing the % change + SEM above control mIPSC amplitude for the 
conditions shown in A.  Event amplitude under control conditions was 43.13 + 
3.88 pA.  D.  Cumulative time course for averaged cells.  The dotted lines 
indicate the averaged value displayed in Fig. B.  (n = 11, * indicates p < 0.05 by 





 Our results demonstrate that ethanol enhances GABAergic transmission 
onto VTA-DA neurons in a concentration-dependent manner in brain slices, and 
that this effect is independent of presynaptic somatic/axonal excitability and 
GABAB receptor modulation.  To our knowledge, this is the first study to 
demonstrate a direct and acute enhancement of GABAergic transmission by 
ethanol in the VTA.  Several labs have reported both pre- and postsynaptic 
enhancement of GABAergic transmission in a variety of other cortical and 
subcortical brain regions in response to acutely administered ethanol.  In rat 
cerebellar slices, acute ethanol increases the frequency of GABAA-mediated 
sIPSCs recorded from granule cells (Carta et al., 2004).  In the rat central 
amygdala (CeA), a brain region important in anxiety and stress responses, 
application of 44 mM ethanol facilitated GABAergic transmission via pre- and 
postsynaptic mechanisms (Roberto et al., 2003).  Two recent reviews discuss the 
strong precedent for acute ethanol to enhance GABA release in the 
hippocampus, central amygdala, cerebellum, and nucleus accumbens (Siggins et 
al., 2005; Weiner and Valenzuela, 2006).  Thus, a strong precedent for ethanol 
modulation of GABAergic transmission exists in a variety of CNS structures. 
 Other labs have demonstrated a reduction of GABAergic neuron 
excitability in the presence of ethanol in the VTA (Stobbs et al., 2004; Xiao et al., 
2007); however neither lab explored GABA release specifically.  It should be 
noted that a decrease in somatic excitability does not exclude a separate action 
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of ethanol to enhance terminal excitability.  Ethanol inhibits NMDA receptors in 
VTA-GABAergic neurons (Stobbs et al., 2004) and this inhibition may partially 
explain the ethanol-induced reduction in GABAergic neuron excitability observed 
by Xial et al.  Additionally, ethanol may increase GABA release by acting on 
terminals of GABAergic medium spiny neurons arising from the NAc and not on 
local VTA interneurons.  Nonetheless, given the strong evidence of ethanol 
facilitation of GABA release in other CNS structures we are confident that our 
results demonstrate specific and direct effects on GABA release. 
It is notable that in the concentration-response experiments in Figure 2, 
we typically did not observe a significant enhancement of GABAergic 
transmission after the initial exposure to 25 mM ethanol.  However, that 
concentration of ethanol following a prior exposure to 15 mM ethanol did result in 
significant enhancement of sIPSC frequency but not amplitude.  One possible 
explanation of this effect of successive applications of ethanol is that such 
intermediate concentrations of ethanol may elicit slowly developing alterations in 
GABAergic transmission and such a time course of slow onset may provide clues 
about potential mechanisms.  On the other hand, an alternative explanation is 
that the lower ethanol concentrations may sensitize synapses to subsequent 
ethanol applications.  Furthermore, it is important to note that we are using young 
rats (21-30 days old) in our experiments.  In a study comparing the effect of 
ethanol on sIPSCs and mIPSCs between juvenile and adult rats, ethanol had a 
greater effect on sIPSCs in adults than juveniles (Li et al., 2006).  However, there 
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were no differences in mIPSCs between the adult and juvenile rats.  Therefore, it 
is possible that the variability seen in our sIPSC recordings with these 
intermediate ethanol concentrations may reflect the slight variability in the ages 
of the rats used within each group of experiments. 
The increase in sIPSC frequency in the presence of ethanol may indicate 
an increase in terminal GABA release probability or an increase in interneuron 
somatic/axonal excitability.  To discern the former from the latter, we measured 
the paired-pulse ratio of evoked IPSCs and the frequency of mIPSCs recorded in 
the presence of TTX.  Under control conditions we observed paired-pulse 
depression; however, acutely applied ethanol further amplified the depression, 
suggesting an increased probability of GABA release from presynaptic terminals.  
Additionally, we saw a robust and reliable increase in mIPSC frequency in the 
presence of ethanol, also suggestive of enhanced GABA release independent of 
interneuron somatic/axonal excitability.  We did not observe a change in mIPSC 
amplitude in the presence of ethanol.  These findings are consistent with other 
reports in which ethanol increases mIPSC frequency while having no effect on 
postsynaptic GABAA receptor sensitivity (Li et al., 2006; Ming et al., 2006; Zhu 
and Lovinger, 2006; Kelm et al., 2007).  Although we did observe variable 
changes in sIPSC amplitude in the presence of ethanol, the lack of change in 
postsynaptic sensitivity with mIPSCs may be a result of the elimination of larger 
action-potential induced events by TTX.  Taken together, our electrophysiological 
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recordings therefore strongly indicate that ethanol positively modulates GABA 
release onto VTA-DA neurons. 
GABAB receptor activation has been implicated in some actions of ethanol 
(Ariwodola and Weiner, 2004) and therefore we assessed the potential 
involvement of GABAB receptors in ethanol modulation of GABA transmission.  
We observed a decrease in sIPSC frequency mediated by the GABAB receptor 
agonist, baclofen, alone which confirmed previous findings (Rohrbacher et al., 
1997).  Conversely, we noted an unexpected increase in frequency following 
application of the antagonist SCH50911 alone which suggests that tonic GABA 
release elicits tonic GABAB receptor-mediated auto-inhibition of GABAergic 
neurons.  Application of the GABAB receptor antagonist presumably removes this 
tonic auto-inhibition, allowing for increased GABA release.  Nevertheless, neither 
activation nor blockade of GABAB receptors appeared to occlude the ethanol 
enhancement in sIPSC frequency indicating ethanol modulation of GABA release 
is independent of GABAB receptors.  Interestingly, application of either the 
GABAB receptor agonist or antagonist completely blocked the enhancement in 
amplitude.  The reason as to the occlusion of the postsynaptic effect is not clear, 
however, there is evidence of GABAB receptor modulation affecting postsynaptic 
GABAA receptor ethanol sensitivity (Wu et al., 2005).  Nevertheless, the initial 
degree of sIPSC amplitude enhancement seen with ethanol (50 mM), while 
significant, is less than 10% over the control sIPSC amplitude value and this 
effect did not reverse upon ethanol washout.  Thus, while we report these small 
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changes in amplitude, we do not feel these constitute convincing evidence to 
indicate that ethanol modulation of sIPSC amplitude is nearly as significant as its 
effects on m/sIPSC frequency and thus its modulation of GABA release.  In this 
regard, we can therefore unequivocally state that the robust presynaptic actions 
of ethanol are not modulated in any manner by activation or inhibition of GABAB 
receptors. 
Multiple labs (including our own – data not shown) have demonstrated an 
enhancement in VTA-DA neuron firing rate and increased dopamine release into 
the NAc after exposure to ethanol and this action is thought to underlie the 
addictive nature of this drug (Brodie et al., 1990; Gonzales and Weiss, 1998; 
Kohl et al., 1998; Brodie et al., 1999b; Okamoto et al., 2006).  Our present 
observations of ethanol enhancement of GABAergic transmission therefore 
would appear to antagonize such stimulatory actions especially since GABAergic 
interneurons regulate DA neuron excitability (Johnson and North, 1992a).  
Furthermore, VTA-DA neurons undergo tonic modulation by GABAergic 
interneurons since prior studies have shown that GABAA receptor blockade 
increases extracellular dopamine levels in the NAc (Ikemoto et al., 1997).  Thus, 
the potentiation of DA neuron excitability by ethanol may be self-limiting due to 
the simultaneous ethanol-induced enhancement in inhibitory drive onto those 
same neurons.  Therefore, there potentially exists a biphasic action of ethanol 
first to increase VTA-DA excitability directly and secondly to enhance GABAergic 
inhibition of VTA-DA neurons.  This inhibitory action of ethanol may in effect 
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constitute an additional pharmacologic action of significant importance that 
results in a balance of inhibitory versus excitatory effects to regulate DA neuron 
firing rate and therefore may constitute an important target for further evaluation.  
A similar effect has recently been observed in cerebellar Purkinje neurons in 
which ethanol has dual actions on these neurons to increase GABA release 
presynaptically while simultaneously acting postsynaptically to increase cell firing 
rate (Ming et al., 2006). 
 While the increase in GABA release by ethanol is insufficient to prevent 
the excitatory effect(s) of ethanol on VTA-DA neurons, whether there exists a 
subset of DA neurons in the VTA that might display differential sensitivity to the 
excitatory and inhibitory effects of ethanol remains to be determined.  This is 
quite possible considering a recent study that discerned two populations of VTA-
DA neurons with differential sensitivity to opioid-mediated presynaptic inhibition 
(Ford et al., 2006).  Nevertheless, our data clearly demonstrate that ethanol 
enhances GABA release in the VTA.  The mechanism(s) underlying this action 
are currently under investigation and preliminary results suggest one potential 
route may involve ethanol enhancement of presynaptic Ca2+ mobilization via a 5-
HT2C-dependent mechanism.  Since ethanol modulation of ventral tegmental DA 
output function is critically involved in reinforcement and reward, identification of 
such regulatory pathways are critical to construct an accurate picture of the 
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Activation of ventral tegmental area (VTA) dopaminergic (DA) neurons by 
ethanol has been implicated in the rewarding and reinforcing actions of ethanol.  
GABAergic transmission is thought to play an important role in regulating the 
activity of DA neurons.  We have previously reported that ethanol enhances 
GABA release onto VTA-DA neurons in a brain slice preparation.  Since intra-
terminal Ca2+ levels regulate neurotransmitter release, we investigated the roles 
of Ca2+-dependent mechanisms in ethanol-induced enhancement of GABA 
release.  Acute ethanol enhanced miniature IPSC (mIPSC) frequency in the 
presence of the nonspecific voltage-gated Ca2+ channel inhibitor, cadmium 
chloride, even though basal mIPSC frequency was reduced by cadmium.  




reticulum Ca2+ ATPase pump inhibitor, cyclopiazonic acid, eliminated the 
ethanol-enhancement of mIPSC frequency.  Recent studies suggest that the G 
protein-coupled receptor, 5-HT2C, may modulate GABA release in the VTA.  
Thus, we also investigated the role of 5-HT2C receptors in ethanol-enhancement 
of GABAergic transmission.  Application of 5-HT and the 5-HT2C receptor agonist, 
Ro-60-0175, alone enhanced mIPSC frequency of which the latter was abolished 
by the 5-HT2C receptor antagonist, SB200646, and substantially diminished by 
cyclopiazonic acid.  Furthermore, SB200646 abolished the ethanol-induced 
increase in mIPSC frequency while having no effect on basal mIPSC frequency.  
These observations suggest that an increase in Ca2+ release from intracellular 
stores via 5-HT2C receptor activation is involved in the ethanol-induced 
enhancement of GABA release onto VTA-DA neurons. 
3-1. Introduction 
The mesolimbic system bidirectionally encodes information related to 
positively- and negatively-reinforcing stimuli, and with conditioning, will adapt its 
output to such stimuli in a manner which encodes the error in reward prediction 
(Schultz et al., 1997).  This capability is primarily processed via ventral tegmental 
area dopaminergic neurons (VTA-DA) which originate in the midbrain nucleus 
A10 and project to the nucleus accumbens (NAc), prefrontal cortex, basolateral 
amygdala and other corticolimbic structures (Albanese and Minciacchi, 1983; 
Oades and Halliday, 1987).  Natural positive-reinforcers activate VTA-DA 
neurons to release DA onto these structures, of which the medium spiny neurons 
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of the NAc constitute the primary VTA-DA target.  Most drugs of abuse 
pharmacologically activate VTA-DA neurons via a variety of mechanisms 
culminating in aberrant release of DA onto these targets and such pathological 
activation of the mesolimbic pathway is considered a primary step in the 
development and expression of drug dependence and addiction.  Thus, acute 
exposure to ethanol increases dopamine levels in the NAc (Weiss et al., 1993).  
Furthermore, chronic exposure to ethanol has been reported to downregulate 
VTA-DA release and this state of dopaminergic hypofunction is thought to 
contribute to alcohol craving in dependent individuals (Rossetti et al., 1992).  
While the mechanisms by which ethanol activates VTA-DA neurons to enhance 
DA output to the NAc are not entirely clear, evidence suggests a direct excitatory 
effect of ethanol on DA neurons in the VTA either though inhibition of delayed-
rectifying K+ channels or modulation of the h-current which underlies the basal 
pacemaker function of VTA neurons (Gessa et al., 1985; Brodie et al., 1999b; 
Okamoto et al., 2006; Koyama et al., 2007). 
Dopamine output from the VTA is regulated by both local GABAergic 
interneurons and GABA containing afferents from the NAc and ventral pallidum 
(Walaas and Fonnum, 1980; Grace and Onn, 1989; Johnson and North, 1992a).  
Remarkably, our understanding of the effects of ethanol on GABAergic 
transmission in the mesolimbic DA system is not well defined and is currently in 
dispute.  We have reported that pharmacologically relevant concentrations of 
ethanol enhance action potential-dependent and -independent GABA release 
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onto VTA-DA neurons (Theile et al., 2008).  On the other hand, Ye and 
colleagues recently demonstrated that ethanol decreases action-potential 
dependent GABA release onto VTA-DA neurons in a manner reversed by the mu 
opioid receptor agonist, DAMGO (Xiao and Ye, 2008).  This discrepancy is 
particularly important since one of the few currently FDA-approved agents for 
alcohol craving - the mu opiate antagonist, naltrexone - is thought to directly 
modulate VTA-GABAergic neuron activity and thus indirectly affect VTA-DA 
neuron firing (Franklin, 1995).  Indeed, naltrexone has been demonstrated to 
block the ethanol-induced increase in NAc dopamine levels in animal models 
(Gonzales and Weiss, 1998).  Thus, in this report we have focused our work to 
uncover VTA-GABAergic regulatory mechanisms which may indirectly modulate 
ethanol effects on VTA-DA output. 
One candidate regulatory pathway to the VTA consists of serotoninergic 
afferents from the midbrain raphe nuclei which innervate both DA and non-DA 
(GABAergic) neurons of the VTA (Herve et al., 1987).  Electrophysiological 
evidence indicates that serotonin (5-hydroxytryptamine; 5-HT) reuptake blockade 
inhibits VTA-DA firing suggesting that a predominant action of 5-HT in the VTA is 
inhibitory and may involve activation of GABAergic neurons (Di Mascio et al., 
1998).  This contention is supported by the observations that (1) 5-HT2C receptor 
(5-HT2CR) activation also inhibits VTA-DA neuron firing (Di Matteo et al., 2000), 
(2) 5-HT2CR mRNA is expressed in GABAergic neurons (Eberle-Wang et al., 
1997) and (3) 5-HT2CRs are localized to both synaptic terminals and cell soma of 
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VTA-GABA neurons though these receptors have also been reported to occur on 
DA neurons as well (Bubar and Cunningham, 2007).  Since 5-HT2CRs facilitate 
phospholipase C-mediated inositol-1,4,5- triphosphate (IP3) accumulation and 
release of Ca2+ from intracellular stores (Conn et al., 1986), activation of this 
pathway on GABAergic soma or terminals could very well result in enhancement 
of GABA release.  Indeed, activation or inhibition of 5-HT2CRs decreases or 
increases respectively, ethanol self-administration by rats (Tomkins et al., 2002).  
Also, enhancement of GABA release by ethanol onto cerebellar Purkinje neurons 
is dependent upon mobilization of Ca2+ from intracellular stores (Kelm et al., 
2007).  Lastly, no prior reports exist which directly assess whether 5-HT2CR 
activation regulates GABA release onto VTA-DA neurons.  Therefore, another 
major impetus for this study is to identify the role of 5-HT2CRs and subsequent 
intracellular Ca2+ mobilization in ethanol facilitation of GABA release onto VTA-
DA neurons. 
3-2. Materials and Methods 
3-2-1. Slice preparation   
All experiments were carried out in accordance with NIH animal use 
guidelines and were approved by the University of Texas Institutional Animal 
Care and Use Committee.  Slices used in this study were prepared from male 
Sprague-Dawley rats (postnatal day 21 to 33).  Rats were anesthetized with 
halothane, decapitated, and the brain was rapidly removed and placed in an ice-
cold choline-based, oxygenated artificial cerebrospinal fluid (aCSF) containing (in 
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mM): 110 choline Cl, 25 NaHCO3, 1.25 NaH2PO4, 2.5 KCl, 25 dextrose, 7 
MgSO4, 0.5 CaCl2, 11.6 Na-ascorbate and 3.1 Na-pyruvate, bubbled with 95% 
O2/5% CO2 (all chemicals obtained from Sigma-Aldrich, St Louis, MO).  
Horizontal midbrain slices (210 µm) were prepared using a vibrating slicer 
(VT1000S; Leica, Nussloch, Germany).  The slices were then maintained at 32oC 
before electrophysiological recordings for a minimum of 60 minutes in aCSF 
containing (in mM): 120 NaCl, 25 NaHCO3, 3.3 KCl, 1.23 NaH2PO4, 10 dextrose, 
2.4 MgSO4, and 1.8 CaCl2, bubbled with  95%O2/5%CO2.   
3-2-2. Electrophysiological recordings of VTA-DA neurons  
Individual slices were transferred to a recording chamber and perfused 
with oxygenated aCSF (30-32oC) at a flow rate of ~2 ml/min.  Recording aCSF 
was as described above except it contained 0.9 mM MgSO4 and 2 mM CaCl2.  
Cells were visualized using IR-DIC optics on an Olympus BX-50WI microscope 
(Leeds Instruments, Irving, TX).  The VTA was identified as being medial to the 
medial terminal nucleus of the accessory optic tract (MT) and rostral to the 
oculomotor nerve (3n) and the medial lemniscus (ml).  The majority of recordings 
were conducted in the lateral VTA, just medial to the MT.  Whole-cell voltage-
clamp recordings were used for all experiments; putative DA neurons were 
identified by the presence of a large hyperpolarization-induced Ih current (>200 
pA) that was measured immediately following break-in by application of a 1.5-s 
hyperpolarizing step from -60 to -110 mV (Johnson and North, 1992b).  
Recording electrodes were made from thin-walled borosilicate glass (TW 150F-4, 
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WPI, Sarasota, Florida, 1.5-2.5 MΩ) and contained (in mM): 135 KCl, 12 NaCl, 
0.5 EGTA, 10 HEPES, 2 Mg-ATP, and 0.3 Tris-GTP, pH 7.3 with KOH (all 
chemicals obtained from Sigma, St Louis, MO).  Data were collected by an Axon 
Instruments Model 200B amplifier filtered at 1 kHz and digitized at 10-20 kHz 
with a Digidata interface using pClamp v9.2 and 10.2 (Molecular Devices, 
Sunnyvale, California).   
GABAergic mIPSCs were pharmacologically isolated with kynurenic acid 
(1 mM) to inhibit AMPA- and NMDA receptor-mediated currents.  Tetrodotoxin 
(TTX; 0.5 µM) and eticlopride (250 nM) were included to block Na+ currents and 
D2 receptor-mediated currents, respectively.  Under these conditions, mIPSCs 
were inward at a holding potential of -60 mV and in an initial set of experiments 
their identity as GABAeric events was verified by testing for block with picrotoxin 
or bicuculline (data not shown).  Following break-in and a stable 10-minute 
baseline (control) recording, drugs were bath-applied through the aCSF perfusion 
line and a continuous 10-15 minute recording epoch was used to detect changes 
in mIPSC frequency and amplitude.  A four-minute drug wash-on preceded the 
start of data collection in each treatment condition, and a 12-min washout period 
followed drug application.  The last half (6 minutes) of the washout period was 
used in our data analysis.  The number of neurons used per each treatment 
condition is represented as n with only one neuron used per slice.  Eticlopride 
hydrochloride, 2-APB, cyclopiazonic acid, bicuculline methiodide and Ro-60-0175 
fumarate were obtained from Tocris Bioscience (Ellisville, MO).  Kynurenic acid, 
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SB200646, nicardipine hydrochloride, cadmium chloride, serotonin hydrochloride 
and picrotoxin were obtained from Sigma-Aldrich (St. Louis, MO).  TTX was 
obtained from Alomone Labs (Jerusalem, Israel).   
3-2-3. Data analysis   
 For mIPSC recordings, quantal events (90-120 sweeps each condition, 5 
sec/sweep) were detected using the template mIPSC detection protocol 
contained within pClampfit (pClamp v9.2, Axon Inst., Molecular Devices).  
Access resistance ranged from 6 to 20 MΩ and was monitored throughout the 
experiment.  Experiments where access resistance changed (>20% at anytime 
during the experiment) were excluded from this study.  To minimize detecting 
small noise deflections as mIPSCs (false positives), events <10 pA were 
discarded.  Treatment and washout groups were normalized to the baseline 
(control) frequency or amplitude and represented as a percentage of the control.  
Averaged values for all data sets are expressed as mean ± SEM and were 
compared statistically using paired student‟s t test, unpaired student's t test, one-
way analysis of variance (ANOVA) and Bonferroni post hoc test where 
mentioned.  The events encompassed in the histogram insets (Fig. 1) were 
compared using a Kolmogorov-Smirnov (K-S) test.  Significant differences were 







3-3-1. Ethanol enhances mIPSC frequency  
 Acute ethanol exposure enhanced GABA release onto VTA-DA neurons 
recorded in an in vitro slice preparation (Theile et al., 2008).  For studies on the 
ethanol concentration-dependence of GABA mIPSCs, a total of 32 VTA-DA 
neurons were exposed to 15, 25, 50 or 75 mM ethanol.  All concentrations 
displayed an increase in mIPSC frequency (Fig 1D) while no consistent change 
in mIPSC amplitude was apparent at any ethanol concentration (data not shown).  
The enhancement in frequency by both 50 and 75 mM were significant compared 
to control (p < 0.05, one-way ANOVA, Bonferroni post-hoc).  There was an 
apparent increase in mIPSC frequency at 15 mM similar to that seen with 25 mM, 
however, the change was not significant.  In response to 25 mM ethanol (legal 
intoxication is 17.4 mM), the frequency of mIPSCs increased by approximately 
20%; mIPSC frequency increased by about 30 and 50% following exposure to 50 
and 75 mM ethanol, respectively.  In order to more thoroughly define the actions 
of ethanol on GABA mIPSC frequency and amplitude, we studied the cumulative 
event distributions for sample neurons at all concentrations tested (only 75 mM 
ethanol shown; Fig 1B/C).  Application of ethanol induced a left-ward shift in the 
cumulative distributions of mIPSC frequency (measured as inter-event interval) 
which were statistically significant at all concentrations tested (K-S test, p < 0.05).  
The shifts in mIPSC frequency distributions were not skewed across different 
frequency ranges and thus were independent of mIPSC frequency itself.  The 
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insets for Fig 1B/C presents an expanded section of the event distributions and is 
centered around the 70-90th percentile level for more detailed comparison 
between treatments and groups.  In all cases, shifts in mIPSC frequency are 
apparent and are evenly distributed across frequencies whereas no changes in 
amplitude distributions are apparent.  Finally, mIPSC frequency washout data 
reflects a notable shift back toward the control (pre-ethanol) population 
distribution. 
 To ensure that changes in postsynaptic or extra-synaptic GABA receptor 
function were not overlooked, we also measured the effects of ethanol on the 
decay time constant, τ, of the mIPSCs as well as the baseline holding current as 
a measure of tonic extra-synaptic GABA receptor function (data not shown).  At 
the highest concentration tested (75 mM) ethanol did not affect decay kinetics, or 
tau (τ), of the mIPSC. Under control conditions, mIPSC decay was 6.8+0.6 ms, 
whereas in the presence of ethanol it was 6.7+0.5 ms (n = 7, p = 0.66).  We 
additionally found no significant effect of ethanol (75 mM) to enhance or induce 
tonic steady-state or “holding” currents recorded from VTA-DA neurons at -60 
mV.  For instance, a sham perfusion buffer exchange resulted in a positive shift 
in the average holding current of 24+10 pA (n = 7), whereas ethanol treatment 















Figure 3-1. Ethanol potentiates mIPSC frequency but not amplitude.  A. 
mIPSCs recorded from a VTA-DA neuron under control conditions, in the 
presence of 75 mM ethanol, and after a washout.  B. Cumulative probability 
histogram of mIPSC inter-event intervals for epochs from a representative 
neuron.  Inset: The leftward shift in IEI distribution in the presence of ethanol is 
significant with respect to baseline (K-S test, p < 0.05).  C.  Cumulative 
probability histogram of mIPSC event amplitudes from the same neuron shown in 
B.  Inset: There is no shift in amplitude distribution in the presence of ethanol with 
respect to baseline (K-S test, p > 0.05).  D. A bar graph representing the % 
change + SEM above control mIPSC frequency at 15, 25, 50, and 75 mM ethanol 
(n = 7 for 15 mM; n = 8 for 25 mM; n = 10 for 50 mM; n = 7 for 75 mM; * indicates 
p < 0.05 different from control, ** indicates p < 0.01 different from control, *† 
indicates p < 0.05 different from 15 mM and **† indicates p < 0.01 different from 




3-3-2. Extracellular Ca2+ influx is not required for the ethanol-induced 
increase in GABA release 
 To determine whether Ca2+ influx from extracellular sites may contribute to 
ethanol-induced enhancement of GABA release, we examined the effects of the 
nonselective voltage-gated Ca2+ channel (VGCC) inhibitor, cadmium chloride 
(CdCl2; 100 µM) on ethanol potentiation of mIPSC frequency (Fig. 2A, B).  In the 
presence of CdCl2 alone, mIPSC frequency markedly decreased indicating that 
influx of Ca2+ may significantly contribute to basal quantal GABA release even 
when action potentials were blocked with TTX.  There was also a slight decrease 
in mIPSC amplitude (91.6 + 2.2% of control; data not shown) in the presence of 
CdCl2 that remained in the presence of ethanol.  Nevertheless, subsequent 
application of ethanol (50 mM) in the continued presence of CdCl2 significantly 
increased mIPSC frequency and therefore reversed the apparent CdCl2 inhibition 
by about 27%.  Following removal of both ethanol and CdCl2 from the perfusate, 
mIPSC frequency reversed to levels substantially greater than the pre-CdCl2 
baseline indicating that prolonged inhibition of extracellular Ca2+ availability may 
induce a complex rebound phenomenon which appears to markedly affect GABA 
release. 
Of the different types of VGCCs, interactions with the L-type VGCC 
subtype and ethanol have been frequently noted (Mullikin-Kilpatrick and 
Treistman, 1995; Hendricson et al., 2003).  GABA release onto the cholinergic 
neurons of Meynert‟s nucleus has been shown to be dependent upon L-type 
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channels (Rhee et al., 1999).  Therefore, we also assessed the effects of the L-
type VGCC antagonist, nicardipine (3 µM) on ethanol potentiation of mIPSC 
frequency (Fig. 2C,D).  Application of this VGCC antagonist resulted in no 
change in either baseline mIPSC frequency (Fig. 2D) or amplitude (data not 
shown).  As observed with CdCl2, in the continued presence of nicardipine, 
subsequent application of ethanol (50 mM) enhanced mIPSC frequency by 
40+13% and slightly increased mISPC amplitude by approximately 8% (control: 
32.1 + 2.2 pA, n = 6, p < 0.05).  Taken together, these results suggest that 
extracellular Ca2+ influx, presumably via N- and/or P/Q-type VGCCs, contribute to 
basal GABA release, whereas L-types do not.  Nevertheless, under no condition 



















Figure 3-2.  Blockade of VGCCs does not inhibit ethanol-induced 
potentiation of mIPSC frequency.  A. mIPSCs recorded from a VTA-DA neuron 
under control conditions, in the presence of 100 µM CdCl2, and 50 mM ethanol 
with 100 µM CdCl2.  B.  A bar graph representing the % change + SEM above 
control mIPSC frequency for the conditions shown in A and a wash.  Event 
frequency under control conditions was 1.7 + 0.3 Hz (n = 10, ** indicates p < 0.01 
by a student‟s t test different from control, *† indicates p < 0.05 by a student‟s t 
test different from CdCl2/EtOH, **† indicates p < 0.01 by a paired student‟s t test 
different from CdCl2 alone).  C. mIPSCs recorded from a VTA-DA neuron under 
control conditions, in the presence of 3 µM nicardipine, and 50 mM ethanol with 3 
µM nicardipine.  D.  A bar graph representing the % change + SEM above control 
mIPSC frequency for the conditions shown in C and a wash.  Event frequency 
under control conditions was 2.0 + 0.4 Hz (n = 6, * indicates p < 0.05 by a 
student‟s t test different from control, ** indicates p < 0.01 by a paired student‟s t 




3-3-3. Intracellular Ca2+ stores are required for ethanol-induced 
enhancement of GABA release 
Ca2+ release from presynaptic IP3- and ryanodine –sensitive internal 
stores is necessary for ethanol potentiation of GABA release onto Purkinje 
neurons in the cerebellum (Kelm et al., 2007).  Thus we investigated the role of 
IP3-sensitive intracellular Ca
2+ in ethanol enhancement of mIPSC frequency 
through the use of two antagonists.  First we assessed the actions of the IP3 
receptor (IP3R) antagonist, 2-Aminoethoxydiphenylborane (2-APB), and 
secondly, we studied an inhibitor of the sarco/endoplasmic reticulum Ca2+ 
ATPase (SERCA) pump, cyclopiazonic acid (CPA) which depletes intracellular 
Ca2+ stores (Seidler et al., 1989).  As also noted by Kelm et al (2007) in their 
studies on Purkinje neurons, application of 2-APB alone (Fig. 3A, B) had no 
significant effect on mIPSC frequency or amplitude.  However, subsequent 
addition of ethanol in the presence of 2-APB did not result in any further change 
in frequency or amplitude as compared to 2-APB alone.  Likewise, application of 
the SERCA pump inhibitor, CPA (10 µM), at a concentration shown to be 
effective in depleting intracellular Ca2+ stores in DA neurons (Morikawa et al., 
2000), completely blocked the enhancement of mIPSC frequency induced by 
subsequent addition of ethanol (50 mM) (Fig. 3C,D).  CPA alone did not change 
mIPSC frequency or amplitude compared to baseline.  These results suggest 
that IP3R-mediated release of Ca
2+ from intracellular stores is required for 





Figure 3-3.  Blockade of intracellular Ca2+ release abolishes ethanol-
induced potentiation of mIPSC frequency.  A. mIPSCs recorded from a VTA-
DA neuron under control conditions, in the presence of 28 µM 2-APB, and 50 mM 
ethanol with 28 µM 2-APB.  B.  A bar graph representing the % change + SEM 
above control mIPSC frequency for the conditions shown in A and a wash.  Event 
frequency under control conditions was 2.1 + 0.6 Hz (n = 6).  C. mIPSCs 
recorded from a VTA-DA neuron under control conditions, in the presence of 10 
µM CPA, and 50 mM ethanol with 10 µM CPA.  D.  A bar graph representing the 
% change + SEM above control mIPSC frequency for the conditions shown in C 
and a wash.  Event frequency under control conditions was 1.3 + 0.3 Hz (n = 9). 
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3-3-4. The 5-HT2CR agonist, Ro-60-0175, and 5-HT increase GABA release 
Recent studies have linked 5-HT2CR activation with modulation of VTA-
GABA and DA transmission (Di Giovanni et al., 2000; Di Matteo et al., 2000; 
Bankson and Yamamoto, 2004).  Therefore, the role of 5-HT2CRs in the ethanol 
enhancement of mIPSC frequency was first investigated by assessing whether 
activation of 5-HT2CRs modulates baseline GABA release.  Application of the 
selective 5-HT2CR agonist, Ro-60-0175 (200 nM), significantly enhanced mIPSC 
frequency (Fig. 4A, B) over a time course that developed relatively slowly (Fig. 
4B, C) and continued to increase throughout the 12 min following removal of the 
drug.  This pattern of prolonged drug action was similar to the prolonged actions 
of ethanol described previously.  Finally, no change in mIPSC amplitude was 
observed (data not shown) in the presence of Ro-60-0175 thereby suggesting 
that 5HT2CR activation solely enhances GABA release.  We verified the 
selectively of the actions of the 5-HT2C agonist by pretreating slices with the 5-
HT2B/2C antagonist, SB200646 (4 µM) and under these conditions, the Ro-60-
0175-induced increase in mIPSC frequency was completely abolished (Fig. 4D, 
E; note the different scales used in 4B vs 4E).   Additionally, application of 5-HT 
(50 µM) produced a significant enhancement in mIPSC frequency (Fig. 5) with no 
subsequent effect on amplitude (data not shown).  Similar to the effects of Ro-60-
0175, the enhancement by 5-HT did not fully wash out and actually increased 













Figure 3-4. 5-HT2CR activation increases GABA release onto VTA-DA 
neurons.  A. mIPSCs recorded from a VTA-DA neuron under control conditions, 
in the presence of 200 nM Ro-60-0175 (after 10 min), and with 200 nM Ro-60-
0175 (after 20 min).  B.  A bar graph representing the % change + SEM above 
control mIPSC frequency for the conditions shown in A and a wash.  Event 
frequency under control conditions was 1.3 + 0.2 Hz.  (n = 8, ** indicates p < 0.01 
by student‟s t test different from control, **† indicates p < 0.01 by student‟s t test 
different from Ro-60 at 10 min)  C.  Time course for a sample representative 
neuron under conditions shown in A.  The dotted lines represent the average 
frequency under each condition for that neuron.  D.   mIPSCs recorded from a 
VTA-DA neuron in continued presence of 4 µM SB200646, with subsequent 
application of 200 nM Ro-60-0175.  E.  A bar graph representing the % change + 
SEM above control mIPSC frequency under for the conditions shown in D and a 
wash to SB200646.  Event frequency under pre-Ro-60-0175 conditions was 1.9 + 




                     
Figure 3-5. 5-HT increases GABA release onto VTA-DA neurons.  A. mIPSCs 
recorded from a VTA-DA neuron under control conditions, in the presence of 50 
µM 5-HT, and after a washout.  B.  A bar graph representing the % change + 
SEM above control mIPSC frequency for the conditions shown in A.  Event 
frequency under control conditions was 1.2 + 0.1 Hz.  (n = 7, * indicates p < 0.05 




3-3-5. Ethanol-enhancement of GABA release is dependent upon 5-HT2CR 
stimulated release of Ca2+ from intracellular stores  
To further validate that mobilization of intracellular Ca2+ is required for the 
5-HT2C agonist activity, we studied the effect of CPA (10 µM) on Ro-60-0175 
enhancement of mIPSC frequency.  Addition of the 5-HT2C agonist following bath 
application of the SERCA pump inhibitor almost completely abolished the 
agonist-induced enhancement of mIPSC frequency (Fig. 6A, B: 17% vs 56% 
increase as seen in Fig. 4B).  Since ethanol appears to enhance GABA release 
through an IP3 cascade which may also be activated by 5-HT2CRs, then 
pharmacological blockade of the 5-HT2CR may significantly reduce or abolish 
ethanol potentiation of mIPSC frequency.  Therefore, we pretreated slices with 
SB200646, for 5-10 minutes prior to application of ethanol (50 mM).  SB200646 
(4 µM) completely prevented the increase in mIPSC frequency normally 
observed after ethanol application (Fig. 6C, D).  There was no effect on mIPSC 
amplitude (data not shown).  These data suggest that in the VTA, 5-HT2CR 

















Figure 3-6. Ethanol-enhancement of GABA release is dependent upon 5-
HT2CR stimulated release of Ca
2+ from intracellular stores.  A.   mIPSCs 
recorded from a VTA-DA neuron in the continued presence of 10 µM CPA, with 
subsequent application of 200 nM Ro-60-0175.  B.  A bar graph representing the 
% change + SEM above control mIPSC frequency for the conditions shown in A.  
Event frequency under pre-Ro-60-0175 conditions was 1.3 + 0.2 Hz.  (n = 6, * 
indicates p < 0.05 by a student‟s t test different from control,).  C. mIPSCs 
recorded from a VTA-DA neuron under control conditions, in the presence of 4 
µM SB200646, and 50 mM ethanol with 4 µM SB200646.  D.  A bar graph 
representing the % change + SEM above control mIPSC frequency for the 
conditions shown in C and a wash.  Event frequency under control conditions 





 In our initial report that characterized ethanol-enhancement of VTA-GABA 
release, we primarily used recordings of spontaneous IPSCs (sIPSCs) which 
demonstrated that ethanol  significantly enhanced sIPSC frequency in a 
concentration-dependent manner (Theile et al., 2008).  Here, we have further 
investigated a variety of potential mechanisms for the ethanol enhancement 
through analysis of action potential-independent mIPSCs.  Ethanol (15, 25, 50 
and 75 mM) clearly increased mIPSC frequency but had no discernable effect on 
the amplitude, decay of mIPSCs or any tonic GABA current.  Baseline mIPSC 
frequency was reduced in the presence of CdCl2; however neither CdCl2 nor the 
L-type VGCC antagonist, nicardipine, prevented ethanol enhancement of GABA 
release.  Blockade of IP3Rs with 2-APB and depletion of intracellular stores with 
CPA both completely abolished the ethanol-induced increase in mIPSC 
frequency.  Finally, addition of both 5-HT and the 5-HT2CR agonist, Ro-60-0175, 
increased mIPSC frequency over a similar time course as that seen with ethanol.  
Blockade with the 5-HT2CR antagonist, SB200646, abolished ethanol 
enhancement of mISPC frequency as well as that following application of the 
selective 5-HT2CR agonist.  Thus, our primary conclusion is that the ethanol-
induced enhancement in GABA release onto VTA-DA neurons is mediated via 5-
HT2CR activation which under normal conditions would subsequently release 
Ca2+ from IP3-sensitive stores. 
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 While our prior report was the first to assess ethanol modulation of GABA 
release in VTA (Theile et al., 2008),  Ye and colleagues recently reported that 
ethanol (10-40 mM) may have differential effects on VTA action potential-
dependent GABA release.  Thus, while under control conditions ethanol 
appeared to decrease GABA release, an increase in sIPSC frequency was 
observed in the presence of saturating concentrations of the mu-opioid receptor 
(MOR) agonist DAMGO (Xiao and Ye, 2008).  The authors contend that 
application of DAMGO silences VTA interneurons via activation of somatic and 
dendritic MORs thereby unmasking the stimulatory effect of ethanol on other 
GABAergic inputs.  To us, the most parsimonious explanation for these 
somewhat disparate findings is that, under control conditions, our VTA slice 
preparation must possess a higher level of endogenous opioid tone and thus 
mimic the conditions demonstrated by Xiao et al. (2008).  On the other hand, 
Bergevin et al. (2002) has reported the presence of MORs on GABAergic 
terminals in the VTA.  This observation complicates the hypothesis presented by 
Xiao et al. (2008).  Nevertheless, it is also important to note that ethanol has 
been reported to potentiate GABA release in a majority of brain regions studied 
and therefore our observations in the VTA are consistent with the broad literature 
(Siggins et al., 2005; Weiner and Valenzuela, 2006).   
 Activation of VGCCs increases intraterminal Ca2+ levels to initiate 
neurotransmitter release.  Therefore, we examined the role that VGCCs may 
serve in ethanol modulation of GABA release in the VTA.  Typically VGCCs, such 
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as N- and P/Q-type channels, are primarily involved in action potential-dependent 
neurotransmitter release (Wheeler et al., 1994).  Although these experiments 
were conducted in the presence of TTX to block action potentials, L- and P/Q-
type VGCCs have been shown to support GABA release onto Meynert neurons 
independent of action potentials (Rhee et al., 1999).  While application of the 
non-specific VGCC inhibitor, CdCl2, alone resulted in a decrease in the baseline 
mIPSC frequency similar to that observed by another group (Bergevin et al., 
2002), it did not prevent the stimulatory effect of ethanol. However, the 
magnitude of ethanol enhancement was slightly reduced compared to the results 
shown in Figure 1 and this observation may be attributable to a partial depletion 
of the store as a result of extended blockade of extracellular Ca2+ influx.  
Application of nicardipine, an L-type channel inhibitor, had no effect on baseline 
mIPSC frequency and similarly did not block the ethanol-induced enhancement 
in mIPSC frequency.  These results suggest that while certain VGCCs contribute 
partly to basal VTA-GABA release, they are not important in the mechanism of 
ethanol-enhancement of GABA release. 
 Since influx of Ca2+ through VGCCs does not appear to underlie ethanol 
stimulation of GABA release, we next investigated the dependency of ethanol 
enhancement on intracellular Ca2+ stores.  Ethanol enhancement of intracellular 
Ca2+ levels is well documented in the literature.  Early work showed that 
pharmacologically relevant concentrations of ethanol facilitated Ca2+ release from 
IP3 sensitive stores in brain microsomes (Daniell and Harris, 1989).  Additionally, 
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release of Ca2+ from presynaptic cytosolic pools can facilitate GABA release in a 
variety of brain regions (Savic and Sciancalepore, 1998; Rhee et al., 1999; Kelm 
et al., 2007).  Application of the IP3R antagonist, 2-APB, prevented the ethanol 
enhancement of mIPSC frequency.  These findings are comparable to recent 
observations in the cerebellum (Kelm et al., 2007).  High concentrations of 2-APB 
have been suggested to lack selectivity, yet such issues arise at concentrations 
higher than 80 µM (Missiaen et al., 2001).  Therefore, we used a considerably 
lower concentration and did not observe any non-specific effects as 
demonstrated by the lack of change in mIPSC frequency in the presence of 2-
APB alone.  We further tested the dependency of intracellular Ca2+ stores by 
depleting these stores using the SERCA pump inhibitor, CPA.  Application of 
CPA likewise had no effect on baseline mIPSC frequency and subsequent 
application of ethanol failed to elicit the reliable increase in mIPSC frequency. 
Together with the 2-APB results, we conclude that IP3-mediated Ca
2+ release is 
necessary for ethanol-induced enhancement in GABA release. 
 DA output from the VTA is modulated by 5-HT-containing neurons 
originating from the midbrain raphe nuclei which innervate both DA and non-DA 
neurons (Herve et al., 1987).  5-HT2CR activation leads to phosphatidylinositol 
turnover and subsequent Ca2+ release via IP3R activation (Conn et al., 1986).  
Modulation of midbrain DA neuron activity via 5-HT2CRs is believed to occur 
indirectly through changes in GABAergic transmission (Di Giovanni et al., 2000).  
Here, we demonstrated a 5-HT2CR-dependent increase in GABA release since 
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application of 5-HT or the selective 5-HT2CR agonist, Ro-60-0175, resulted in a 
prolonged enhancement in mIPSC frequency of which the latter effect was 
abolished in the presence of the 5-HT2C selective antagonist, SB200646.  This 
enhancement was also substantially reduced by the SERCA pump inhibitor, 
CPA, suggesting this component is Ca2+ mediated.  Most importantly, we 
observed that blockade with SB200646 abolished the ethanol-mediated 
enhancement in GABA release.  These results are consistent with previous 
studies.  Methylenedioxymethamphetamine („ecstasy‟) increases GABA release 
in the VTA through a 5-HT2CR-dependent mechanism (Bankson and Yamamoto, 
2004).  In the substantia nigra, local and systemic administration of Ro-60-0175 
was observed to stimulate GABA release (Invernizzi et al., 2007).  Thus, while 
we cannot rule out other metabotropic receptors which may also activate GABA 
release in an ethanol-responsive manner as we report here, it does appear that 
the 5-HT2CR is a prime candidate for the physiological regulation of GABA 
release in the VTA and a target of ethanol modulation as well.  
 Multiple labs have demonstrated that ethanol produces an acute 
enhancement of VTA-DA neuron excitability.  Here and in a previous report 
(Theile et al., 2008), we observe a seemingly contradictory enhancement in 
inhibitory drive onto VTA-DA neurons.  Thus, ethanol possesses an apparent 
biphasic action to directly enhance both DA neuron excitability and inhibitory 
drive onto DA neurons.  This concept may have implications for the development 
of novel therapies for treating alcohol craving.  For instance, the MOR antagonist, 
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naltrexone, is one of the few approved agents for craving.  One prominent action 
of MOR activation is a reduction in GABA release onto VTA-DA neurons, thus 
enhancing their excitability (Johnson and North, 1992a; Bergevin et al., 2002).  
Therefore, we hypothesize that a derangement in VTA-GABA function, at least in 
part, may underlie ethanol dependence and craving.  Consequently, one possible 
therapeutic mechanism of MOR antagonism may be to normalize GABA release 
and thus amplify the ethanol-induced increase in GABA release to diminish or 
temper the direct reinforcing action of ethanol on VTA-DA neurons.  Since we 
show herein that activation of 5-HT2CRs enhances GABA release and is critical in 
ethanol modulation of GABAergic inhibition onto VTA-DA neurons, novel 
pharmacotherapies for alcohol craving might focus on this mechanism for directly 
enhancing inhibitory drive onto these neurons. 
 Here, we demonstrate that ethanol enhances VTA-GABA release in a 
manner that is dependent on activation of 5-HT2CRs, which activate the IP3 
receptor cascade and, subsequently, Ca2+ release from intracellular stores.  We 
consider that the most logical site of ethanol action is upstream of the 5-HT2CR.  
Ethanol increases 5-HT release in the NAc (Yoshimoto et al., 1992) and prevents 
5-HT reuptake in the hippocampus (Daws et al., 2006).  Therefore, it is 
conceivable that ethanol may also stimulate 5-HT release in the VTA which 
subsequently results in the activation of 5-HT2CRs.  This is certainly a possibility 
given that application of 5-HT enhances GABA release in our preparation.  
Nevertheless, given the results presented here, 5-HT2C/IP3R activation 
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represents a primary candidate for the mechanism by which ethanol enhances 
GABA release in the VTA and taken together this novel action of ethanol may 






















Chapter 4:  Role of GABA and opioids in the regulation of VTA-
DA neuron firing rate 
4-1. Introduction 
 GABAA receptors are present on VTA-DA neurons and GABA release 
tonically inhibits these neurons (Yim and Mogenson, 1980; Johnson and North, 
1992a; Johnson and North, 1992b; Westerink et al., 1996).  It is well established 
that acute ethanol stimulates VTA-DA neuron activity in Sprague-Dawley rats 
both in vivo (Gessa et al., 1985) and in vitro (Brodie et al., 1990), as well as in 
mice (Brodie and Appel, 2000).  However, we have evidence demonstrating an 
ethanol enhancement of GABA release onto VTA-DA neurons (Theile et al., 
2008; Theile et al., 2009) implying that ethanol potentially has a dual action on 
VTA-DA neuron activity.  As a result, we hypothesized that the ethanol-
enhancement in GABA release may limit the overall stimulatory effect of ethanol 
on VTA-DA neuron activity.  
 Furthermore, it has been demonstrated that activation of MORs on 
GABAergic interneurons in the VTA disinhibits VTA-DA neuron activity (Johnson 
and North, 1992a; Margolis et al., 2003; Xiao et al., 2007).  The MOR agonist, 
DAMGO, reduced the frequency of miniature and spontaneous IPSCs through 
inhibition of the secretory process at the nerve terminal of GABAergic cells 
(Bergevin et al., 2002).  In the CeA, ethanol increased GABA release and this 
effect was enhanced in DOR knock-out mice and in the presence of DOR 
antagonists (Kang-Park et al., 2007).  The authors contend that endogenous 
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opiate release negatively modulates spontaneous and ethanol-induced GABA 
release in the CeA.  Based on these studies and on our own data showing an 
ethanol-induced enhancement of GABA release, we hypothesized that the 
ethanol-induced increase in GABA release is masked by the endogenous opioid 
tone acting on MORs localized on interneurons.  Inhibition of MORs with the non-
selective opioid antagonist, naltrexone, may uncover a tonic inhibition of GABA 
release, thus amplifying the ethanol-induced increase in GABA release.  The 
resultant increase in GABA transmission may then overcome the direct effect of 
ethanol on DA neuron excitability, thereby providing a possible mechanism to 
explain the ability of naltrexone to block ethanol-induced increases in dialysate 
dopamine levels in the NAc of male Wistar rats (Gonzales and Weiss, 1998), and 
possibly may contribute to the clinical efficacy of naltrexone on preventing 
relapse in recovering alcoholics. 
4-2. Materials and Methods 
4-2-1. Slice preparation   
All experiments were carried out in accordance with NIH animal use 
guidelines and were approved by the University of Texas Institutional Animal 
Care and Use Committee.  Slices used in this study were prepared from male 
Long Evans rats (postnatal day 21 to 28).  Rats were anesthetized with 
halothane, decapitated, and the brain was rapidly removed and placed in an ice-
cold choline-based, oxygenated artificial cerebrospinal fluid (aCSF) containing (in 
mM): 110 choline Cl, 25 NaHCO3, 1.25 NaH2PO4, 2.5 KCl, 25 dextrose, 7 
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MgSO4, 0.5 CaCl2, 11.6 Na-ascorbate and 3.1 Na-pyruvate, bubbled with 95% 
O2/5% CO2 (all chemicals obtained from Sigma-Aldrich, St Louis, MO).  
Horizontal midbrain slices (210 µm) were prepared using a vibrating slicer 
(VT1000S; Leica, Nussloch, Germany).  The slices were then maintained at 32oC 
before electrophysiological recordings for a minimum of 60 minutes in aCSF 
containing (in mM): 120 NaCl, 25 NaHCO3, 3.3 KCl, 1.23 NaH2PO4, 10 dextrose, 
2.4 MgSO4, and 1.8 CaCl2, bubbled with  95%O2/5%CO2.   
4-2-2. Electrophysiological recordings of VTA-DA neurons  
Individual slices were transferred to a recording chamber and perfused 
with oxygenated aCSF (30-32oC) at a flow rate of ~2 ml/min.  Recording aCSF 
was as described above except it contained 0.9 mM MgSO4 and 2 mM CaCl2.  
Cells were visualized using IR-DIC optics on an Olympus BX-50WI microscope 
(Leeds Instruments, Irving, TX).  The VTA was identified as being medial to the 
MT and rostral to the oculomotor nerve and the ml.  The majority of recordings 
were conducted in the lateral VTA, just medial to the MT.  For action potential 
recordings, putative DA neurons were identified by their characteristic slow (1-5 
Hz) pacemaking activity.  Additionally, whole-cell access was obtained and 
putative DA neurons were further identified by the presence of a large 
hyperpolarization-induced Ih current (>200 pA) that was measured immediately 
following break-in by application of a 1.5-s hyperpolarizing step from -60 to -110 
mV (Johnson and North, 1992b).  For mIPSC recordings, DA neurons were 
identified via the presence of an Ih current before the experiment was carried out.  
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Recording electrodes were made from thin-walled borosilicate glass (TW 150F-4, 
WPI, Sarasota, Florida, 1.5-2.5 MΩ) and contained (in mM): 135 KCl, 12 NaCl, 
0.5 EGTA, 10 HEPES, 2 Mg-ATP, and 0.3 Tris-GTP, pH 7.3 with KOH (all 
chemicals obtained from Sigma, St Louis, MO).  Data were collected by an Axon 
Instruments Model 200B amplifier filtered at 1 kHz and digitized at 20 kHz (for 
mIPSCs) and 50 kHz (for action potentials) with a Digidata interface using 
pClamp v10.2 (Molecular Devices, Sunnyvale, California).   
Firing rate recordings were conducted in the absence of any 
channel/receptor drugs except where mentioned.  Action potential firing rate was 
measured using tight-seal current clamp recordings because rupture of the cell 
membrane under traditional whole-cell recordings significantly disrupts the 
pacemaking activity of DA neurons (Morikawa et al., 2003).  Following formation 
of a tight seal and a stable 10-minute baseline (control), drugs were bath applied 
through the aCSF perfusion line and a continuous 15-17 minute recording epoch 
was used to detect changes in firing rate.  A 10-minute washout followed drug 
application.    
GABAergic mIPSCs were pharmacologically isolated with kynurenic acid 
(1 mM) to inhibit AMPA- and NMDA receptor-mediated currents.  Tetrodotoxin 
(TTX; 0.5 µM) and eticlopride (250 nM) were included to block Na+ currents and 
D2 receptor-mediated currents, respectively.  Under these conditions, mIPSCs 
were inward at a holding potential of -60 mV and in an initial set of experiments 
their identity as GABAergic events was verified by testing for block with picrotoxin 
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or bicuculline (data not shown).  Following break-in and a stable 10-minute 
baseline (control) recording, drugs were bath-applied through the aCSF perfusion 
line and a continuous 10-15 minute recording epoch was used to detect changes 
in mIPSC frequency and amplitude.  A four-minute drug wash-on preceded the 
start of data collection in each treatment condition, and a 12-min washout period 
followed drug application.  The number of neurons used per each treatment 
condition is represented as n with only one neuron used per slice.  SCH50911, 
muscimol and DAMGO were obtained from Tocris Bioscience (Ellisville, MO).  
Kynurenic acid, naltrexone hydrochloride and picrotoxin were obtained from 
Sigma-Aldrich (St. Louis, MO).  TTX was obtained from Alomone Labs 
(Jerusalem, Israel).    
4-2-3. Data analysis   
 For firing rate recordings, action potentials (30-50 sweeps each condition, 
20 sec/sweep) were detected using a threshold detection protocol contained with 
pClampfit (pClamp v10.2, Axon Inst., Molecular Devices).   The peak 5 minutes 
of the drug effect and the last 5 minutes of washout were normalized to the last 5 
minutes of the baseline (control) and represented as a percentage of the control.  
Averaged values for all data sets are expressed as mean ± SEM and were 
compared statistically using paired student‟s t test, unpaired student's t test and 
one-way analysis of variance (ANOVA) test where mentioned.     
 For mIPSC recordings, quantal events (90-120 sweeps each condition, 5 
sec/sweep) were detected using the template mIPSC detection protocol 
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contained within pClampfit.  Access resistance ranged from 8 to 25 MΩ and was 
monitored throughout the experiment.  Experiments where access resistance 
changed (>20% at anytime during the experiment) were excluded from this study.  
To minimize detecting small noise deflections as mIPSCs (false positives), 
events <10 pA were discarded.  Treatment and washout groups were normalized 
to the baseline (control) frequency or amplitude and represented as a percentage 
of the control.  Averaged values for all data sets are expressed as mean ± SEM 
and were compared statistically using paired student‟s t test and unpaired 
student's t test where mentioned.   
4-3. Results 
4-3-1. Ethanol transiently enhances firing rate of VTA-DA neurons in vitro. 
 Acute ethanol has been demonstrated to increase the firing rate of DA 
neurons in the VTA of Sprague-Dawley rats both in vivo (Gessa et al., 1985) and 
in vitro (Brodie et al., 1990), as well as in mice (Brodie and Appel, 2000).  In Long 
Evans rats, ethanol administration produced a robust transient increase in 
dopamine release in the NAc as measured via microdialysis (M. Job, 
unpublished observations).  Here, we demonstrate electrophysiologically a 
similar response in acute brain slices from Long Evans rats.  Acute application of 
ethanol (75 mM) produced a large, transient increase in the firing rate of VTA-DA 
neurons that reversed upon washout (Fig. 1).  This transient increase in firing 
rate reached a peak of 15.7 + 2.1% above baseline within the first five minutes of 
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ethanol application (termed the „rising phase‟) before approaching baseline levels 








       
Figure 4-1.  Ethanol produces transient enhancement of VTA-DA neuron 
firing rate.  A.  Cumulative graph displaying average firing rate of VTA-DA 
neurons treated with 75 mM ethanol (n = 30).  Data points for individual cells 
represent 20-sec sweeps in which the average firing rate (Hz) was calculated.  
Each data point is normalized to the last 5 mins of baseline.  The normalized 
data points were combined to obtain the graph above.  Error bars represent the 
SEM of averaged time points.  B.  A bar graph representing the % change + SEM 
above control firing rate.  The bar graph represents the peak 5-min ethanol 
response and the last 5 mins of washout (n = 30, ** indicates p < 0.01 by a 




4-3-2. GABA modulates VTA-DA neuron firing rate   
 GABAA receptors are present on VTA-DA neurons and GABA release has 
been shown to tonically inhibit these neurons (Yim and Mogenson, 1980; 
Johnson and North, 1992a; Johnson and North, 1992b; Westerink et al., 1996). 
Interestingly, some reports suggest the majority of GABAA receptors are 
expressed on GABAergic cells and activation of these receptors results in 
disinhibition, rather than inhibition, of DA neurons in the VTA (Kalivas et al., 
1990; Churchill et al., 1992; Xi and Stein, 1998; Laviolette and van der Kooy, 
2001; Doherty and Gratton, 2007).  We demonstrate here that application of the 
GABAA receptor antagonist picrotoxin (75 µM) alone had a disinhibitory effect to 
increase VTA-DA firing rate (Fig. 2A).  Picrotoxin increased the firing rate to a 
peak of about 4.1 + 1.9% above baseline (n = 14, p<0.05 by student‟s t-test). 
Although the effect is slight, these results give support to the role of postsynaptic 
GABAA receptors in modulating DA neuron activity.  Conversely, application of 
the potent GABAA receptor agonist muscimol (1 µM) substantially inhibited the 
firing of VTA-DA neurons (Fig. 2B).  Muscimol decreased firing rate to about 56.4 
+ 10.4% of baseline (n = 8, p<0.05 by student‟s t-test).     
GABAB receptors are located at pre- and postsynaptic sites in the VTA 
with activation of presynaptic GABAB receptors resulting in a decrease in GABA 
release (Melis et al., 2002).  However, some argue that the majority of GABAB 
receptors are at postsynaptic sites on DA cells (Xi and Stein, 1998) and 
activation of these receptors with baclofen decreases DA output to the NAc 
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(Westerink et al., 1996; Amantea and Bowery, 2004).  Therefore we measured 
the effect of the GABAB receptor antagonist, SCH50911 (20 µM), on VTA-DA 
neuron firing rate.  In the presence of SCH0911 alone, firing rate was moderately 
increased (Fig. 2C).  SCH50911 increased the firing rate to a peak of about 4.4 + 
1.9% above baseline (n = 13, p<0.05 by student‟s t-test).  This suggests that 
there may indeed be some postsynaptic GABAB receptors regulating VTA-DA 
neuron activity.  Lastly, complete blockade of both GABAA and GABAB receptors 
with dual application of SCH50911 and picrotoxin produced an even greater 
increase in VTA-DA firing rate than with either alone (Fig. 2D).  Co-application of 
picrotoxin and SCH50911 increased the firing rate to a peak of about 12.1 + 
3.3% above baseline (n = 12, p<0.05 by student‟s t-test).  Overall, these results 
further support the notion that there is enough GABA tone present in vitro to 
modulate VTA-DA activity, and that basal GABA release tonically inhibits VTA-











Figure 4-2.  GABAA receptor activation and blockade modulate VTA-DA 
neuron activity.  Cumulative graph displaying average firing rate of VTA-DA 
neurons treated with (A) 75 µM picrotoxin (n = 14), (B) 1 µM muscimol (n = 8; 
note different scale), (C) 20 µM SCH50911 (n = 13) and (D) picrotoxin and 
SCH50911 (n = 12).  Data points for individual cells represent 20-sec sweeps in 
which the average firing rate (Hz) was calculated.  Each data point is normalized 
to the last 5 mins of baseline.  The normalized data points were combined to 
obtain the graph above.  Error bars represent the SEM of averaged time points.  
The average baseline firing rates were for (A) 2.2 + 0.3 Hz, (B) 2.5 + 0.3 Hz (C) 




















4-3-3. Ethanol-enhancement of VTA-DA neuron firing rate is self-limiting   
 We have previously demonstrated that acute ethanol application results in 
a long-lasting increase in GABA release onto VTA-DA neurons in Sprague-
Dawley rats (Theile et al., 2008; Theile et al., 2009).  As previously mentioned, 
ethanol produced a transient enhancement in VTA-DA firing rate in acute slices 
from Long Evans rats.  We hypothesized that an ethanol-enhancement in GABA 
release may play a role in the transient nature of the excitatory effect of ethanol 
on firing rate.  As in Sprague-Dawley rats, acute application of ethanol (75 mM) 
markedly increased mIPSC frequency while having no effect on amplitude in 
slices from Long Evans rats (Fig. 3).  Therefore, ethanol enhances DA neuron 
activity while concurrently increasing inhibitory drive onto those same neurons.  
To investigate these opposite actions and their overall impact on VTA-DA neuron 
activity, we hypothesized that the ethanol-induced increase in GABA release 
antagonizes the ethanol-induced increase in VTA-DA firing rate and 
subsequently facilitates a return towards pre-ethanol activity.  To test this, we 
measured the effects of ethanol on VTA-DA firing rate in the continued presence 
of a saturating concentration of picrotoxin (75 µM).  In the absence of picrotoxin, 
the peak ethanol-induced increase in VTA-DA firing rate was about 16% above 
baseline (Fig. 1).  In the presence of picrotoxin (Fig. 4A), the peak ethanol-
induced increase was 19.3 + 2.7% above baseline (n=14, p<0.01 by student‟s t-
test).  When comparing the peak 5 minute ethanol effect between ethanol alone 
and in the presence of picrotoxin, this difference was significant (One-way 
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ANOVA, p<0.01, F = 20.55).  Additionally, in the presence of picrotoxin, the 
elevated firing rate was sustained for a longer period of time before returning 
towards pre-ethanol levels.  When comparing the last 5 minutes of ethanol 
exposure between ethanol alone and in the presence of picrotoxin, this difference 
was also significant (One-way ANOVA, p<0.01, F = 195.79).  These results 
suggest that one of the factors mediating the falling phase of the ethanol 
response may be a prolonged ethanol-induced enhancement in GABA release.  
To further support this notion, co-application of muscimol and ethanol uncovered 
an inhibitory effect of ethanol on VTA-DA neuron firing rate.  In the presence of 
muscimol (1 µM) alone, VTA-DA neuron firing rate was depressed to about 56% 
of baseline (Fig. 2B) with only 1 of 8 neurons tested exhibiting complete 
cessation in firing.  However, co-application of muscimol and ethanol (75 mM) 
depressed firing rate to 36.5 + 11.5% of baseline with 5 of 9 neurons tested 
exhibiting complete cessation of firing (Fig. 4B).  When comparing the last 5 
minutes exposure between muscimol alone and muscimol with ethanol, this 
difference was significant (One-way ANOVA, p<0.01, F = 45.26).  Thus, under 
conditions of adjunctive GABAA receptor activation ethanol inhibits VTA-DA 









Figure 4-3.  Ethanol enhances mIPSC frequency.  A. mIPSCs recorded from a 
VTA-DA neuron under control conditions, in the presence of 75 mM ethanol and 
a washout.  B.  A cumulative bar graph representing the % change + SEM above 
control mIPSC frequency for the conditions shown in A.  Event frequency under 
control conditions was 1.1 + 0.1 Hz (n = 11, ** indicates p < 0.01 by a student‟s t 
















Figure 4-4.  Ethanol modulation of VTA-DA activity is regulated by GABAA 
receptors.  A. Cumulative graph displaying average firing rate of VTA-DA 
neurons treated with ethanol (75 mM; n = 30; reproduced from Fig. 1) and 
ethanol (75 mM) in the continued presence of picrotoxin (75 µM; n = 14).  The 
average baseline firing rate for ethanol with picrotoxin was 1.9 + 0.1 Hz              
(* indicates p<0.01 by one-way ANOVA).  B. Cumulative graph displaying 
average firing rate of VTA-DA neurons treated with muscimol (1 µM; n = 8; 
reproduced from Fig. 2B) and ethanol (75 mM) with muscimol (n = 9).  The 
average baseline firing rate for ethanol with muscimol was 2.6 + 0.6 Hz               
(* indicates p<0.01 by one-way ANOVA).  For both A and B, data points for 
individual cells represent 20-sec sweeps in which the average firing rate (Hz) 
was calculated.  Each data point is normalized to the last 5 mins of baseline.  
The normalized data points were combined to obtain the graphs above.  Error 


















4-3-4. Mu-opioid receptor activation inhibits GABA release onto VTA-DA 
neurons 
 Bergevin et al. (2002) demonstrated a clear effect of DAMGO, a selective 
MOR agonist, to reduce the frequency, but not amplitude, of both GABAA 
receptor-mediated sIPSCs and mIPSCs as recorded from VTA-DA neurons of 
Sprague-Dawley rats.  Additionally, acute ethanol has been demonstrated to 
enhance opioid levels in the VTA in vivo (Jarjour et al., 2009).  It is unknown if 
this occurs in an in vitro preparation.  Therefore, we investigated whether ethanol 
application could enhance GABA release in the presence of a MOR agonist.  
Application of DAMGO alone (3 µM) significantly decreased mIPSC frequency 
(Fig. 5) while having no significant effect on mIPSC amplitude (data not shown).  
These results support the idea proposed by Bergevin et al. (2002) that activation 
of MORs, likely on GABAergic terminals synapsing onto DA neurons, decreases 
vesicular release at these terminals via an action-potential independent 
mechanism.  Following the decrease in mIPSC frequency by DAMGO alone, co-
application of DAMGO (3 µM) and ethanol (75 mM) potentiated mIPSC frequency 
(Fig. 5).  When normalized to DAMGO alone, ethanol enhanced mIPSC 
frequency by about 32%.  Additionally, there is no significant effect on mIPSC 
amplitude under either condition (data not shown).  These results suggest that 




                          
Figure 4-5.  DAMGO does not block ethanol-enhancement of mIPSC 
frequency.  A. mIPSCs recorded from a VTA-DA neuron under control 
conditions, in the presence of 3 µM DAMGO and 75 mM ethanol with 3 µM 
DAMGO.  B.  A cumulative bar graph representing the % change + SEM above 
control mIPSC frequency for the conditions shown in A and a wash.  Event 
frequency under control conditions was 1.2 + 0.2 Hz (n = 8, ** indicates p < 0.01 
by student‟s t test different from control, *† indicates p < 0.05 by a paired 
student‟s t test different from DAMGO, *†† indicates p < 0.05 by a paired 
student‟s t test different from DAMGO, * indicates p < 0.05 by Student‟s t test 
different from control).  
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4-3-5. Mu-opioid receptor activation does not alter VTA-DA neuron firing 
rate 
 VTA-DA neuron activity is partly regulated via MOR-mediated inhibition of 
GABA release.  Several labs have demonstrated an MOR-mediated disinhibition 
of VTA-DA neurons in Sprague-Dawley rats (Johnson and North, 1992a; 
Margolis et al., 2003; Xiao et al., 2007).  Since we observed a substantial 
decrease in GABA release with DAMGO, we would expect to see a disinhibitory 
effect of DAMGO on VTA-DA neuron firing rate.   Using tight-seal cell-attached 
current-clamp recordings we measured the firing rate of VTA-DA neurons in the 
presence of the MOR-selective agonist, DAMGO.  The peak response to 
DAMGO was not significantly greater than the baseline firing rate at 1 µM (n = 8, 
p>0.05 by student‟s t-test, Fig. 6A) or 3 µM (n = 9, p>0.05 by student‟s t-test, Fig. 
6A).  We speculate that the presence of a strong GABA tone is necessary in 
order to see a disinhibitory effect of DAMGO on VTA-DA neuron firing rate in 
vitro.  Since there was no change in firing rate at either 1 or 3 µM DAMGO, we 
raised the extracellular K+ concentration ([K+]o) from 3.3 mM to 7 mM.  Increasing 
the [K+]o in the recording solution would hypothetically increase GABAergic 
neuron activity, thus increasing GABA tone in the slice.  After establishing a 
stable baseline firing frequency, the high [K+]o solution was washed on before 
application of DAMGO.  Although the addition of the higher [K+]o solution 
dramatically increased the VTA-DA firing rate (73.2 + 6.8% above baseline, n = 
6, p<0.01 by student‟s t-test), subsequent addition of DAMGO did not result in 
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any further change in the firing rate (72.9 + 7.7% above baseline, p>0.05 by 
paired student‟s t-test compared to high [K+]o alone, Fig. 6B).  Increasing [K
+]o not 
only increases GABA drive onto VTA-DA neurons, but also increases 
glutamatergic drive as well.  Therefore, we repeated the experiment with 
kynurenic acid in the recording solution to block NMDA- and AMPA receptor-
mediated currents (Fig. 6C).  Under these conditions, addition of the high [K+]o 
solution increased firing rate to 49.7 + 11.5% above baseline (n = 7, p<0.01 by 
student‟s t-test).  However, application of DAMGO had no further effect on DA 
neuron firing rate (38.1 + 14.4% above baseline, p>0.05 by paired student‟s t-test 
compared to high [K+]o alone).  The extent of the increase in firing rate with high 
[K+]o solution in the presence of kynurenic acid did not reach the level as that 
seen in high [K+]o alone.  These observations suggest that the high [K
+]o solution 
increases glutamatergic transmission while also directly depolarizing VTA-DA 
neurons.  Nevertheless, under no conditions did we observe any evidence of 
MOR regulation of VTA-DA firing rate.     
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Figure 4-6.  DAMGO does not modulate VTA-DA neuron activity.  Cumulative 
graph displaying average firing rate of VTA-DA neurons treated with (A) 1 µM 
DAMGO (n = 8) and 3 µM DAMGO (n = 9), (B) 3 µM DAMGO with 7 mM [K+]o (n 
= 6) and (C) 3 µM DAMGO with 7 mM [K+]o and 1 mM kynurenic acid (n = 7).  
Data points for individual cells represent 20-sec sweeps in which the average 
firing rate (Hz) was calculated.  Each data point is normalized to the last 5 mins 
of baseline.  The normalized data points were combined to obtain the graph 
above.  Error bars represent the SEM of averaged time points.  The average 
baseline firing rates were for (A) 2.3 + 0.2 Hz for 1 µM and 2.7 + 0.3 Hz for 3 µM, 
(B) 1.7 + 0.3 Hz and (C) 2.1 + 0.3 Hz.  
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4-3-6. Mu-opioid receptor blockade has no effect on GABA tone or ethanol-
enhancement of VTA-DA neuron activity 
 Blockade of MORs with naltrexone (Gonzales and Weiss, 1998) and the 
more specific MOR antagonist naloxonazine, along with genetic deletion of 
MORs, (Job et al., 2007) attenuates ethanol-enhancement of DA release into the 
NAc, therefore suggesting the opioidergic system positively modulates the 
excitatory effect of ethanol on DA neuron activity in vivo.  Furthermore, ethanol 
increases GABA release in the CeA and this effect is enhanced in DOR knock-
out mice and in the presence of DOR antagonists (Kang-Park et al., 2007).  The 
latter study suggests that endogenous opiate release negatively modulates 
spontaneous and ethanol-enhanced GABA release in the CeA in vitro.  Together 
with our own data showing an ethanol-induced enhancement of GABA release in 
the VTA, we hypothesized that the ethanol-induced increase in GABA release is 
limited by endogenous or ethanol-enhanced opioid tone acting on MORs 
localized to interneurons, thus inhibition of MORs with naltrexone may uncover a 
tonic inhibition of GABA release.  The resulting increase in GABAergic 
transmission in the presence of ethanol may then suppress or inhibit the 
excitatory effect of ethanol on DA neuron activity.  This may provide a possible 
mechanism to explain the ability of naltrexone to block ethanol-induced increases 
in dialysate dopamine levels in the NAc.  To test this hypothesis, we first 
examined the effect of naltrexone (60 µM) alone and with ethanol (75 mM) on 
mIPSCs (Fig. 7).  Naltrexone had no effect on mIPSC frequency.  Since we did 
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not observe an enhancement in mIPSC frequency following MOR blockade, this 
suggests that there is no basal opioid tone in our slice preparation.  Naltrexone 
also did not potentiate the ethanol-enhancement in mIPSC frequency, but in fact 
the ethanol effect appeared slightly less robust, since when normalized to 
naltrexone alone, ethanol enhances mIPSC frequency by about 28%.     
 Additionally, we measured VTA-DA firing rate under normal conditions and 
in the presence of ethanol (75 mM).  Application of naltrexone alone at 20 µM 
(2.1 + 1.5% above baseline, n = 9, p>0.05 by student‟s t-test) and 60 µM (1.6 + 
3.1% of baseline, n = 8, p>0.05 by student‟s t-test) had no effect on VTA-DA 
firing rate.  Additionally, naltrexone did not block the ethanol-induced 
enhancement in VTA-DA firing rate (Fig. 8).  In the continued presence of 20 µM 
naltrexone, ethanol (75 mM) enhanced firing rate by 13.7 + 2.2% above baseline 
(n = 8, p<0.01 by student‟s t-test).  In the presence of 60 µM naltrexone, ethanol 
enhanced firing rate by 21.2 + 3.2% above baseline (n = 11, p<0.01 by student‟s 
t-test).  These results suggest that MOR blockade with naltrexone does not have 
the same effect on VTA-DA neuron activity in vitro as observed in vivo.   
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Figure 4-7.  Naltrexone does not potentiate ethanol-enhancement of mIPSC 
frequency.  A. mIPSCs recorded from a VTA-DA neuron under control 
conditions, in the presence of 60 µM naltrexne and 75 mM ethanol with 60 µM 
naltrexone.  B.  A bar graph representing the % change + SEM above control 
mIPSC frequency for the conditions shown in A and a wash.  Event frequency 
under control conditions was 1.6 + 0.3 Hz (n = 8, * indicates p < 0.05 by student‟s 
t test different from control, *† indicates p < 0.05 by a paired student‟s t test 







Figure 4-8.  Naltrexone does not block ethanol-enhancement in VTA-DA 
firing rate.  Cumulative graph displaying average firing rate of VTA-DA neurons 
treated with 75 mM ethanol with 20 µM naltrexone present throughout (n = 8) and 
75 mM ethanol with 60 µM naltrexone present throughout (n = 11).  Data points 
for individual cells represent 20-sec sweeps in which the average firing rate (Hz) 
was calculated.  Each data point is normalized to the last 5 mins of baseline.  
The normalized data points were combined to obtain the graph above.  Error 
bars represent the SEM of averaged time points.  The average baseline firing 









 In our initial studies, we demonstrated an ethanol-induced enhancement in 
GABA release onto VTA-DA neurons of Sprague-Dawley rats (Theile et al., 2008; 
Theile et al., 2009).  From those studies we concluded that the ethanol 
enhancement in GABA release is likely mediated via 5-HT2C receptor activation 
and subsequent release of calcium from intracellular stores.  Ethanol has been 
demonstrated to enhance VTA-DA neuron activity in vivo (Gessa et al., 1985) 
and in vitro (Brodie et al., 1990); thus in this chapter we have focused on how the 
ethanol-enhancement of GABA release fits in with the results from those studies 
and numerous others.  Here we demonstrate that acute application of ethanol 
enhanced both the firing rate of putative VTA-DA neurons as well as GABA 
release onto those same neurons in Long Evans rats.  GABAA and GABAB 
receptor blockade also stimulated VTA-DA neuron activity, thus demonstrating 
that basal GABA release tonically inhibits VTA-DA neurons in our slice 
preparation.  Moreover, the excitatory effect of ethanol on VTA-DA neuron 
activity appears to be partly limited by a concurrent ethanol-enhancement in 
GABA release.  In the presence of picrotoxin, ethanol stimulation of VTA-DA 
firing was significantly more robust and sustained at a greater level, whereas in 
the presence of muscimol, ethanol inhibited VTA-DA firing.  Additionally, MOR 
activation with DAMGO decreased GABA release but had no apparent 
disinhibitory effect on VTA-DA neuron firing rate.  Conversely, MOR blockade 
with the antagonist naltrexone had no effect on either basal or ethanol-enhanced 
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GABA release.  Although naltrexone has been demonstrated to block the 
stimulatory effect of ethanol on VTA-DA neuron activity in vivo (Gonzales and 
Weiss, 1998; Job et al., 2007), we did not observe this result in our slice 
preparation.   
 Ethanol (75 mM) application produced a robust and reliable increase in 
VTA-DA neuron firing rate that consisted of two phases: a rising and falling 
phase.  Immediately after ethanol was introduced into the bath, there was a rapid 
increase in firing rate that peaked for a few minutes before slowly falling and 
stabilizing at a level intermediate between the baseline and peak responses.  
These results suggest that the maximal excitatory effect of ethanol on VTA-DA 
excitation is not maintained throughout the entire duration of ethanol exposure, 
but rather reaches an initial peak before some other process acts to diminish the 
excitation to that approaching pre-ethanol conditions.  In this report we 
demonstrated that GABA modulates VTA-DA firing rate and that ethanol 
enhances GABA tone.  As a result, we hypothesized that an ethanol-induced 
enhancement in inhibitory drive is one factor that dampens the excitatory effect of 
ethanol on firing rate.  Indeed, in the presence of saturating concentrations of 
picrotoxin (75 µM), the peak excitatory effect of ethanol was larger and sustained 
for a longer period of time.  Furthermore, while the GABAA receptor agonist 
muscimol strongly inhibited VTA-DA firing rate, this inhibition was more 
pronounced in the presence of ethanol.  Thus, while ethanol-enhancement of 
GABA release alone is not enough to overcome the direct excitatory effect of 
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ethanol on VTA-DA neuron activity, these results demonstrate that conditions of 
adjunctive GABAA receptor activation can reverse the stimulatory effect of 
ethanol on VTA-DA neuron activity.  We speculate that GABAA receptor 
activation by muscimol antagonizes the initial excitatory effect of ethanol on firing 
rate and a long-lasting ethanol-induced enhancement in GABA release produces 
further inhibition.  Thus, these results support the idea that the excitatory effect of 
ethanol on VTA-DA neuron activity is self-limiting and that GABAA receptors 
represent a „gain switch‟ regulating the overall stimulatory/inhibitory effect of 
ethanol.      
GABAA receptors are present on VTA-DA neurons and GABA release 
tonically inhibits these neurons (Yim and Mogenson, 1980; Johnson and North, 
1992a; Johnson and North, 1992b; Westerink et al., 1996).  Interestingly, some 
reports suggested the majority of GABAA receptors are expressed on GABAergic 
cells and activation of these receptors results in disinhibition, rather than 
inhibition, of DA neurons in the VTA (Kalivas et al., 1990; Churchill et al., 1992; 
Xi and Stein, 1998; Laviolette and van der Kooy, 2001; Doherty and Gratton, 
2007).  However, here we demonstrate that blockade of GABAA receptors 
disinhibited VTA-DA firing and activation of GABAA receptors strongly inhibited 
VTA-DA firing.  These results suggest that GABAA receptors are primarily 
expressed on VTA-DA neurons.  
 VTA-DA neuron activity is partly regulated via MOR-mediated inhibition of 
GABA release.  Several labs have demonstrated an MOR-mediated disinhibition 
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of VTA-DA neurons in Sprague-Dawley rats (Johnson and North, 1992a; 
Margolis et al., 2003; Xiao et al., 2007).  It should be noted, however, that in the 
study by Margolis et al. (2003), disinhibition was seen in only 47% of the neurons 
tested.  Additionally, in the study by Johnson and North (1992a), the use of an 
elevated [K+]o solution was required to observe disinhibition.  In line with the 
results of another study (Bergevin et al., 2002), we demonstrate that DAMGO 
application decreased mIPSC frequency consistent with an MOR-mediated 
inhibition of GABA release.  Therefore, we investigated whether the decrease in 
GABA tone would translate to an increase in the excitability of VTA-DA neurons.  
In the presence of DAMGO (1-3 µM), there was neither a change in DA neuron 
firing rate under normal recordings conditions nor in the presence of an elevated 
[K+]o solution and kynurenic acid.  These results are surprising considering that 
we did observe a considerable reduction in GABA release in the presence of 
DAMGO.  It is possible that the addition of the higher [K+]o solution created a 
„ceiling effect‟ on the VTA-DA neuron activity, thus preventing any further 
excitation upon addition of DAMGO.  Interestingly, kynurenic acid appeared to 
dampen the overall excitability of the neurons in the presence of the higher [K+]o  
solution.  This suggests that glutamatergic terminals are also excited with the 
higher [K+]o solution.  In the study by Xiao et al. (2007), they observed a 
disinhibitory effect of DAMGO on DA neuron excitability in the VTA of Sprague-
Dawley rats under normal recording conditions.  We cannot fully explain why we 
do not see similar results; however, the use of coronal slices in that study may 
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partly explain the different observations seen here.  We also demonstrate that 
ethanol application enhanced GABA release even in the presence of DAMGO.  
This is important considering that acute ethanol has been demonstrated to 
enhance endogenous opioid levels in the VTA in vivo (Jarjour et al., 2009) and 
MOR activation inhibits GABA release.  Thus, as suggested previously (Theile et 
al., 2009), the mechanism of ethanol modulation of GABA release is clearly 
distinct from that of opioid modulation.  
 Naltrexone has been demonstrated to reduce the ethanol-induced 
enhancement in dopamine release from the VTA (Gonzales and Weiss, 1998; 
Job et al., 2007).  However, the exact mechanism for this is unclear.  We 
demonstrate here that ethanol reliably enhanced GABA release in the VTA and 
that GABA release is modulated via MOR activation.  Therefore, we 
hypothesized that if there is opioid tone in our slice preparation, then blockade 
with naltrexone may enhance GABA tone resulting in a greater ethanol effect on 
GABA release.   Indeed, genetic deletion of MORs in the CeA of mice increased 
GABA tone (Kang-Park et al., 2009).  Upregulation of GABA tone could 
overcome a direct excitatory effect of ethanol on DA neuron activity.  However, 
we do not observe any change in GABA release in the presence of naltrexone 
(20-60 µM).  Moreover, naltrexone did not block the ethanol-induced 
enhancement in VTA-DA neuron firing rate.  Thus, we do not observe in vitro the 
ability of naltrexone to suppress the ethanol enhancement in VTA-DA neuron 
activity as seen in vivo.  Opioid tone is likely substantially reduced or absent in 
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our slice preparation due to deafferentation, thus representing one of the few 
drawbacks to studying synaptic transmission in an in vitro slice preparation.  
Similarly, DOR antagonism in the VTA has no effect on GABA release although 
application of a DOR agonist strongly suppresses GABA release in low-drinking 
animals (Margolis et al., 2008).  The results of that study also suggest that opioid 
tone is absent in a slice preparation.  Furthermore, in the study by Kang-Park et 
al. (2009) there is no observable effect of MOR deletion on ethanol-enhancement 
of GABA release in the CeA, although they previously demonstrated an ethanol 
interaction with DORs (Kang-Park et al., 2007).  Conversely, in the hippocampus, 
naltrexone at 60 µM, but not 30 µM, inhibits the ethanol-induced enhancement in 
sIPSC frequency (Li et al., 2009).     
 Interestingly, in the presence of naltrexone (60 µM), the ethanol-
enhancement in firing rate did not exhibit the pronounced falling phase as seen 
with ethanol alone.  We can only speculate as to the reason for this result.  In 
addition to being localized to cell bodies and axon terminals of GABAergic 
neurons in the VTA, MORs are also present on a subset of DA cell bodies and 
dendrites (Garzon and Pickel, 2001).  These DA neurons are classified as tertiary 
neurons and are differentiated from principle neurons in that they are inhibited by 
MOR agonists (Cameron et al., 1997; Margolis et al., 2003).  Therefore, if ethanol 
application increases opioid release under our conditions, it is possible that MOR 
blockade would promote a longer lasting ethanol-induced excitation of DA neuron 
activity.  Additionally, KORs are also present on principle DA neurons and 
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activation of these receptors results in inhibition of firing (Margolis et al., 2003).  
Naltrexone is non-selective, especially at high concentrations, thus KOR 
blockade may result in a disinhibitory effect on firing rate and could explain our 
observations.   
 Overall, these results highlight the differences in VTA-DA activity when 
measuring in vitro versus in vivo.  Although we observed an apparent modulatory 
role of GABA on ethanol stimulation of VTA-DA firing rate, the same cannot be 
said for opioid modulation.  The results presented here do help to reconcile the 
fact that ethanol stimulates VTA-DA neuron activity while simultaneously 
enhancing GABAergic input onto those same neurons.  For the first time, we 
observed an inhibitory effect of ethanol on VTA-DA neuron firing under conditions 
of additional GABAA receptor activation.  This may have implications with regards 
to the use of GABAA agonists in the treatment of alcohol dependence.  GABA, 
and perhaps opioids, may not be the only factors mediating the falling phase of 
the ethanol-enhancement in VTA-DA neuron activity.  Ethanol directly excites 
VTA-DA neurons through a variety of mechanisms including, but not limited to, 
enhancement of the Ih current (Okamoto et al., 2006) and a reduction in a 
voltage-dependent K+ current (Koyama et al., 2007).  The falling phase of the 
ethanol response could be partly attributable to a development of an acute 
tolerance of one or more of these elements.  In conclusion, the results presented 
here confirm previous findings in other animal models but give new insight into 
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the mechanism of ethanol modulation of VTA-DA neuron activity while also 




















Chapter 5: Concluding remarks and future studies 
 An important question that remains concerns the relevance of the present 
findings to the mechanism of alcohol dependence.  This question can be better 
answered by studying the effects of both acute and chronic ethanol on synaptic 
transmission in the VTA.  Therefore, any forthcoming conclusions from the 
present study must reflect the fact that there have been no studies investigating 
the effects of chronic ethanol exposure on GABA release in the VTA.  However, 
one study did demonstrate that VTA-DA neurons are sensitized to ethanol after 
chronic exposure since acute application of ethanol enhanced VTA-DA firing 
more in chronically treated rats than in ethanol-naïve rats (Brodie, 2002).  
Notably, the sensitivity of DA neurons to GABA was reduced in chronically 
treated animals.  Whether or not decreased sensitivity to GABA of VTA-DA 
neurons reflects any compensatory changes due to changes in GABAergic 
transmission remains uninvestigated.  
 Obviously, ethanol is used intermittently and our understanding of 
changes in VTA-DA and GABA interactions during withdrawal is less well-
documented.  Several studies have examined the effects of long-term ethanol 
administration on GABAergic transmission; however, there is a lack of consensus 
between brain regions and in the type of ethanol administration paradigm used.  
In the hippocampus, withdrawal from chronic intermittent ethanol (CIE) treatment 
results in a decrease in mIPSC frequency as recorded from CA1 neurons 
(Cagetti et al., 2003).  Although subsequent exposure to acute ethanol was not 
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examined in that study, a previous study in the hippocampus demonstrated an 
enhancement in ethanol sensitivity to evoked IPSCs (Kang et al., 1998).  
Conversely, in the amygdala, continuous chronic ethanol exposure results in an 
enhancement in GABA release (Roberto et al., 2004).  Furthermore, the authors 
observed that acute ethanol similarly enhanced GABA release in both chronic 
treated and ethanol naïve rats, thus suggesting a lack of tolerance to acute 
ethanol.  Nonetheless, based on the results presented by Brodie (2002) there 
must be some factor regulating the altered sensitivity of VTA-DA neurons to 
GABAA receptor-mediated inhibition.  Prolonged GABA release induced by 
ethanol may impart compensatory changes in GABAA receptor expression and/or 
function to account for the results seen by Brodie (2002).  Indeed, chronic GABA 
release can decrease GABAA receptor subunit expression and GABAA receptor-
mediated inhibition (Kumar et al., 2009).  Furthermore, Melis et al. (2002) 
demonstrated that a single in vivo injection of ethanol resulted in a long-lasting 
enhancement in GABA release.  Thus it is possible that ethanol-induced changes 
in GABA release could contribute to the altered VTA-DA sensitivity to GABA-
mediated inhibition.  As a result, it would be pertinent to investigate the effects of 
long-term ethanol exposure on GABA release in the VTA, in vitro and in vivo, 
using multiple ethanol administration paradigms. 
 When examining the results of the present study we must also ask 
whether the observed effects of ethanol on GABAergic transmission and 
subsequent regulation of VTA-DA neuron activity demonstrated in vitro occur in 
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vivo.  We clearly demonstrated a discrepancy in opioid receptor modulation of 
basal and ethanol-enhanced VTA-DA neuron activity between our in vitro 
preparation and in vivo preparations from other studies (Di Chiara and Imperato, 
1988; Klitenick et al., 1992; Yoshida et al., 1993; Gonzales and Weiss, 1998; 
Mathon et al., 2005; Job et al., 2007).  This discrepancy highlights the 
importance of repeating many of the same experiments described in this study in 
the whole animal.  No studies have investigated ethanol-mediated changes in 
GABA levels in the VTA in vivo and such an investigation would be a logical next 
step.  Additionally, it would be interesting to investigate whether local application 
of picrotoxin or muscimol to the VTA could modulate the ethanol-induced 
increase in NAc dopamine levels.  
 As demonstrated in the results of Chapter 4, GABAA receptor activation 
appears to function as a switch regulating VTA-DA activity in the presence of 
ethanol.  GABAA receptor blockade results in a greater ethanol-mediated 
enhancement in VTA-DA neuron firing rate as compared to normal conditions.  
Conversely, GABAA receptor activation with muscimol uncovers an ethanol-
mediated inhibition in VTA-DA neuron firing rate.  This switch from ethanol 
stimulation to inhibition may have implications for the rewarding and reinforcing 
properties of ethanol.  In the whole animal, strong ethanol stimulation of 
neighboring brain regions with GABAergic projections to the VTA in conjunction 
with local GABAergic stimulation could overcome the direct excitatory effect of 
ethanol on VTA-DA neuron activity.  Additionally, in those that become 
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dependent, basal and/or ethanol-enhanced GABA release may initially be 
minimal or become weaker after chronic exposure.  This would correlate to a 
more robust excitatory effect of ethanol on VTA-DA neuron activity and thus 
ethanol consumption could potentially be more reinforcing.  Conversely, those 
who are less susceptible to dependence may exhibit robust basal and/or ethanol-
enhanced GABA release, thereby curbing the excitatory effect of ethanol on 
VTA-DA neuron activity.  This in turn would theoretically limit the reinforcing 
attribute of ethanol on the mesolimbic system.  It would be very interesting to 
investigate potential differences in the acute effects of ethanol on GABA release 
between strains of animals that are genetically pre-disposed to drink more or 
less.  Those animal strains which are genetically prone to drink less or not at all 
(alcohol non-preferring) should exhibit a strong basal GABA tone and/or a robust 
ethanol-enhancement in GABA release which would correlate with a weaker 
reinforcing effect of acute ethanol.  Conversely, those strains which are 
genetically prone to drink more (alcohol preferring) may exhibit a weak GABA 
tone and/or a weaker ethanol-enhancement in GABA release and thus exhibit a 
strong reinforcing effect of ethanol.  In fact, in Sardinian alcohol-preferring rats, 
the frequency of mIPSCs recorded from VTA-DA neurons under control 
conditions was considerably less than that in non-preferring rats (Melis et al., 
2009).   
 In conclusion, this dissertation effectively demonstrates a stimulatory 
effect of ethanol on GABAergic transmission in the VTA.  5-HT2C receptor 
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activation and subsequent release of calcium via intracellular stores represents 
at least one mechanism by which ethanol stimulates GABA release.  
Interestingly, ethanol appears to have dual actions on VTA activity whereby 
ethanol excites VTA-DA neurons directly while simultaneously stimulating GABA 
release onto those neurons.  Obviously, to gain a better and potentially more 
accurate understanding of the effects of ethanol on VTA activity it would be 
prudent to repeat many of these experiments in the whole animal.  Nonetheless, 
the results presented here represent novel findings that can further our 
understanding of the acute effects of ethanol in the VTA and could lead to the 
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